rfhg_150231.1

Basic information about the TSS

---

TSS ID: rfhg_150231.1 Species: human Chr: chr12		Start: 49742132 End: 49742157 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2556891,EH38E1610370)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC036203:14 GeneID: 7009 HGNC/MGI_ID: HGNC:11723 UniProt_ID: Nearer transcript ids and distances:

Gene_name: TMBIM6 Gene_symbol: TMBIM6 Gene_synonyms: BAXI1 BI-1 Gene_source: HGNC:11723

TATA-Box annotation

---

Distance to TSS:	335
Nearest PromoterID:	NM_001098576
Entrez ID:	7009
Nearest Unigene:	Hs.743965
Nearest Refseq:	NM_003217
Nearest Ensembl:	ENSG00000139644
Gene Name:	TMBIM6
Gene Alias:	BAXI1|BI-1|TEGT
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.538462
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TMBIM6 p2@TMBIM6 p3@TMBIM6 p4@TMBIM6 p5@TMBIM6 p6@TMBIM6 p7@TMBIM6 p8@TMBIM6 p9@TMBIM6
Sample		p1@TMBIM6	p2@TMBIM6	p3@TMBIM6	p4@TMBIM6	p5@TMBIM6	p6@TMBIM6	p7@TMBIM6	p8@TMBIM6	p9@TMBIM6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	518.96	23.96	1.36	6.43	6.23	2.92	7.21	2.34	5.65
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	547.07	24.89	1.62	5.66	5.66	1.42	10.32	2.43	7.08
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	549.58	24.11	0.77	8.10	5.21	2.51	7.52	3.09	5.02
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	479.44	21.62	1.04	7.90	4.37	2.49	6.45	2.49	4.78
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	484.13	21.82	2.02	5.40	6.30	2.02	6.52	2.47	3.82
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	556.62	21.51	2.71	6.01	6.40	2.13	5.04	1.94	3.49
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	669.34	27.02	3.92	8.50	8.28	1.74	7.19	4.58	4.58
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	559.77	40.94	2.91	3.63	8.48	1.45	5.81	4.84	4.12
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	501.38	36.12	2.14	4.06	7.27	1.07	5.77	2.14	3.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	290.39	12.75	30.72	3.48	4.06	1.16	4.06	2.90	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	258.71	12.94	25.06	2.02	4.85	2.02	3.64	2.43	7.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	264.67	10.98	28.46	1.22	5.69	0.81	1.63	1.22	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	279.19	22.41	0.00	6.29	0.32	2.58	3.22	2.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	334.23	23.76	0.00	7.67	0.75	3.16	2.86	4.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	262.37	20.42	0.00	6.37	1.10	1.98	4.17	1.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	266.08	22.38	0.00	8.55	0.00	3.52	3.77	3.52	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	298.56	26.43	0.00	4.59	0.66	1.97	4.15	3.28	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	252.25	16.45	0.00	7.59	0.42	5.91	5.48	3.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	272.98	14.40	0.00	13.86	0.53	3.20	1.60	1.60	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	248.38	19.11	0.00	6.77	0.90	2.86	3.91	3.01	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	302.19	22.19	0.00	6.55	1.20	3.61	4.14	2.81	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	315.21	20.71	0.00	8.63	0.86	3.28	3.28	3.80	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	324.82	20.68	0.00	5.43	0.39	2.46	2.20	3.10	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	282.95	21.11	0.00	8.25	1.46	3.40	3.40	3.15	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	281.72	18.32	0.00	6.71	0.77	3.35	3.87	3.87	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	269.98	16.46	0.00	6.33	0.63	3.80	4.43	1.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	301.65	13.19	0.00	6.59	1.10	2.75	4.95	3.30	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	370.37	21.22	0.00	6.37	0.94	2.59	3.30	4.72	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	258.76	18.90	0.00	7.91	0.48	2.91	4.36	3.23	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	322.30	22.44	0.00	5.97	0.18	3.08	3.44	3.62	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	280.52	19.05	0.00	9.42	0.42	4.19	5.02	5.23	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	263.96	18.76	0.00	5.47	0.39	1.56	3.71	3.52	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	300.29	18.36	0.00	11.61	0.42	2.74	6.96	4.01	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	485.58	34.14	0.00	10.56	0.33	2.64	5.44	4.45	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	295.44	24.31	0.00	9.16	0.93	2.06	4.86	5.98	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	274.98	18.97	0.19	6.13	0.57	4.79	2.87	3.45	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	313.72	23.71	0.00	6.13	0.82	2.86	2.86	4.70	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	333.66	23.98	0.00	9.07	0.40	3.22	4.23	6.04	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	308.19	25.66	0.00	6.75	1.35	2.16	2.43	4.86	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	286.87	23.29	0.00	4.56	0.72	2.40	3.60	3.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	317.84	24.47	0.00	8.47	0.71	2.82	4.71	2.12	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	402.00	28.40	0.15	8.34	1.32	1.90	5.27	5.42	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	277.54	21.30	0.00	8.22	0.84	4.22	3.80	5.91	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	287.24	17.83	0.00	5.24	0.70	2.62	4.72	4.55	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	303.77	22.09	0.20	6.42	1.00	3.01	5.62	4.82	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	285.92	19.54	0.00	11.17	0.93	5.12	4.65	6.98	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	290.05	22.07	0.00	7.92	1.20	3.12	4.08	4.80	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	282.25	25.04	0.00	8.35	0.30	2.98	3.58	4.77	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	290.60	25.61	0.00	5.27	0.72	2.87	2.15	5.51	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	281.26	23.05	0.00	5.46	0.61	4.45	4.04	4.25	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	340.63	31.56	0.00	17.22	1.84	6.56	3.69	6.97	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	369.14	26.46	0.00	10.23	1.11	7.34	8.01	5.34	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1049.41	97.95	0.00	55.97	0.00	0.00	69.96	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	311.21	30.16	0.00	7.45	0.71	3.90	4.97	3.55	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	339.34	31.81	0.00	11.60	0.66	4.64	5.63	2.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1226.53	102.35	0.00	43.62	3.36	6.71	15.94	15.94	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	698.97	55.57	0.00	26.64	3.21	5.97	8.73	8.27	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	361.38	23.34	0.00	10.70	0.97	7.13	8.10	5.83	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	303.83	23.12	0.00	7.71	0.96	6.74	4.50	4.18	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	657.26	51.86	0.63	16.97	1.57	6.29	9.74	11.94	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	325.73	26.09	0.00	8.46	0.00	9.17	7.76	5.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	336.47	29.72	0.00	14.02	0.00	6.17	8.41	3.93	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	738.02	70.86	0.00	24.68	4.78	25.48	11.94	11.94	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	516.45	42.47	1.02	16.31	0.34	7.47	8.83	5.10	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	337.59	18.85	0.32	9.42	1.30	9.75	2.27	3.90	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	317.71	20.94	0.35	11.00	1.06	7.10	6.39	2.48	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	759.70	96.98	0.00	48.49	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1113.54	71.08	0.00	15.79	0.00	0.00	31.59	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	319.32	32.66	0.00	13.65	0.49	9.75	5.36	3.41	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	389.26	33.72	0.00	14.88	0.50	5.45	5.95	5.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	408.60	34.25	0.00	7.97	1.41	4.69	4.69	2.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	439.49	35.11	0.33	9.94	0.66	5.30	4.64	4.97	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	344.92	30.01	0.31	14.23	0.31	8.35	4.33	5.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	325.62	27.82	1.22	5.50	0.61	6.73	3.67	2.45	0.61
Adipocyte - breast, donor1	11376-118A8	659.99	43.71	6.18	2.85	2.69	1.43	2.22	2.06	1.11
Adipocyte - breast, donor2	11327-117E4	455.93	37.70	2.09	7.06	0.48	1.44	3.37	4.33	1.93
Adipocyte - omental, donor1	11473-119C6	788.56	53.69	18.58	4.58	1.91	1.65	1.91	3.94	2.04
Adipocyte - omental, donor2	11474-119C7	419.34	38.87	0.75	6.73	0.00	0.00	4.48	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	472.57	37.18	2.34	3.01	0.67	3.01	4.35	4.02	2.01
Adipocyte - perirenal, donor1	11476-119C9	486.15	35.73	1.28	1.28	1.28	2.55	6.38	3.83	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	257.28	28.59	4.40	0.00	1.10	0.00	1.10	2.20	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	557.30	37.03	4.52	2.71	0.00	1.81	1.35	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	434.44	26.76	0.17	1.39	0.17	1.74	1.22	2.09	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	382.54	37.75	0.59	0.59	1.76	1.96	0.98	0.98	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	312.20	18.02	0.26	1.54	0.51	1.54	0.77	0.26	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	420.95	20.07	0.84	1.12	0.84	0.28	0.56	0.28	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	257.46	14.11	1.18	0.00	0.59	2.35	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	503.03	35.23	0.08	1.21	1.85	1.37	0.72	1.13	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	415.06	22.59	1.29	1.29	0.65	2.90	0.65	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	376.43	16.53	0.53	1.60	0.00	1.07	3.20	3.73	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	334.42	15.58	0.56	1.11	1.11	0.56	1.11	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	506.14	51.15	0.00	2.50	1.25	2.91	1.25	3.33	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	498.06	34.66	0.25	1.51	0.50	1.26	2.51	2.01	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	431.64	31.74	0.98	1.96	1.96	1.96	1.64	0.00	2.95
Adipocyte differentiation, day12, donor4	13030-139E6	312.69	26.49	0.30	0.30	0.00	0.91	1.22	0.91	2.74
Alveolar Epithelial Cells, donor1	11510-119G7	664.76	49.28	2.65	0.88	0.66	0.66	0.22	0.44	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	211.56	19.36	0.72	1.79	0.00	0.72	0.36	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	213.25	11.98	1.20	1.20	2.40	0.00	0.00	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	557.53	44.08	1.62	1.44	0.36	0.54	1.26	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	321.31	25.10	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	392.61	28.56	0.21	1.23	0.82	1.44	1.03	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	574.99	38.56	0.00	0.34	0.92	0.80	1.03	0.92	0.23
Anulus Pulposus Cell, donor2	11463-119B5	254.21	23.02	0.00	0.73	1.71	1.22	2.45	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	378.76	23.36	0.45	4.49	0.45	1.35	3.59	2.70	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	406.36	28.65	0.43	2.17	0.00	2.17	1.30	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	316.76	29.96	0.00	6.42	0.00	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	401.75	24.51	0.30	4.48	0.90	1.49	4.18	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	432.51	29.09	0.00	5.06	1.26	1.26	3.79	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	267.99	23.76	0.00	5.94	0.00	2.64	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	361.92	27.29	0.32	1.30	0.65	1.30	3.57	2.60	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	419.42	33.98	0.00	2.43	1.46	3.40	2.43	1.94	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	344.45	21.38	0.00	3.56	0.59	1.78	2.97	2.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	407.52	32.01	1.13	2.64	0.38	0.38	4.52	2.64	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	400.57	25.40	0.00	2.90	0.73	2.18	4.35	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	309.68	20.06	0.00	3.76	1.25	0.00	5.02	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	457.80	35.09	0.16	0.99	0.33	0.82	0.66	0.49	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	391.70	15.01	0.00	4.09	0.00	1.36	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	371.40	29.10	0.75	1.66	1.06	1.21	0.60	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	436.13	22.50	0.00	2.14	1.61	0.54	2.68	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	319.11	28.53	0.19	1.89	0.19	0.94	1.70	0.76	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	355.22	22.72	0.00	2.67	0.00	1.07	1.87	1.87	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	334.58	17.56	1.95	1.95	0.00	3.90	3.90	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	349.13	26.70	0.00	1.33	0.50	1.00	1.00	1.49	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	333.80	26.42	0.00	3.60	0.00	2.40	2.40	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	396.50	24.78	0.00	10.62	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	356.78	32.08	0.00	1.72	0.17	1.03	0.86	0.86	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	327.21	4.19	0.00	12.58	0.00	0.00	8.39	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	423.29	26.21	0.00	3.88	1.46	2.43	4.85	2.43	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	408.67	27.70	0.00	3.04	0.76	1.14	3.04	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	333.13	23.02	0.00	7.27	0.00	0.00	9.69	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	441.78	28.50	0.00	4.56	1.14	2.28	3.42	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	351.02	30.36	0.00	2.57	0.86	1.07	2.14	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	279.00	21.68	0.00	1.81	0.77	0.52	1.81	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	381.00	25.34	0.00	0.94	0.94	1.41	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	317.05	26.69	0.32	0.96	0.64	2.57	3.54	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	306.07	24.97	0.71	1.43	0.71	0.71	1.43	2.14	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	380.80	26.32	0.00	1.75	0.00	0.00	0.00	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	339.91	26.19	0.30	3.31	0.00	0.00	3.01	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	325.51	23.76	0.00	7.13	0.00	3.56	3.56	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	454.14	27.97	0.51	3.56	0.00	1.53	7.12	2.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	374.39	27.25	0.00	3.82	0.00	0.76	3.82	3.82	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	304.34	23.51	0.64	3.18	0.64	1.91	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	390.11	26.76	1.29	2.59	0.00	0.00	3.02	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	333.83	31.33	0.00	2.96	0.42	2.12	1.69	1.27	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	295.78	22.04	0.00	2.61	0.29	1.16	3.19	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	372.23	22.67	0.00	4.72	0.00	1.89	1.89	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	326.00	25.77	0.17	2.71	0.51	1.19	1.19	0.68	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	347.45	23.16	0.00	9.27	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	411.95	27.46	0.00	2.11	0.00	0.00	2.11	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	358.71	32.38	0.21	3.00	1.07	1.29	2.14	1.50	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	359.79	28.88	0.00	2.41	0.00	2.41	2.41	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	398.75	23.33	0.00	5.10	0.00	1.46	3.64	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	383.44	27.13	0.23	3.68	1.15	1.15	1.38	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	367.24	22.95	0.00	10.20	0.00	0.00	12.75	7.65	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	440.07	32.80	0.25	1.78	0.25	2.03	1.02	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	369.73	29.31	0.00	2.68	0.62	0.62	2.89	0.83	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	318.24	19.89	0.00	1.84	0.31	1.53	2.75	0.92	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	490.44	24.86	0.00	2.39	0.96	1.43	6.21	2.39	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	338.38	24.39	0.00	1.55	0.22	1.55	1.55	1.33	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	337.20	22.89	0.00	6.10	0.00	6.10	0.00	4.58	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	387.72	26.59	0.00	1.11	0.55	1.11	3.32	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	350.06	30.19	0.00	2.12	0.53	1.59	0.53	1.06	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	345.28	20.35	0.00	2.54	0.73	1.09	3.63	1.45	0.73
Astrocyte - cerebellum, donor1	11500-119F6	604.38	57.72	0.98	0.86	3.19	1.11	0.49	0.86	0.61
Astrocyte - cerebellum, donor2	11580-120F5	259.99	27.21	0.00	2.57	1.54	0.86	0.68	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	275.82	21.39	2.73	0.63	1.47	1.05	0.42	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	768.28	50.89	0.00	2.79	0.70	1.05	1.39	2.79	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	457.50	39.80	0.49	4.37	1.62	1.13	2.75	1.94	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	529.07	38.19	0.00	2.83	1.19	2.24	1.79	1.79	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	362.75	38.76	9.29	1.95	2.18	0.80	1.03	1.03	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	349.54	41.97	6.26	0.50	2.00	1.75	1.63	1.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	319.77	36.87	8.53	1.02	2.05	0.57	0.80	0.34	0.00
Basophils, donor1	12241-129G9	534.05	27.20	0.78	0.52	0.78	0.52	0.26	0.26	1.57
Basophils, donor2	12242-129H1	544.80	37.16	0.72	0.36	1.44	0.36	0.36	0.72	2.16
Basophils, donor3	12243-129H2	408.65	22.20	0.73	0.73	0.73	1.18	0.15	0.15	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	479.72	37.95	2.16	2.37	0.65	1.08	1.08	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	167.33	15.09	0.00	0.46	0.91	0.46	0.46	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	373.03	21.52	0.00	0.00	0.00	7.17	0.00	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	254.83	14.44	0.63	3.14	1.26	0.63	1.26	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	252.45	19.96	0.00	0.21	0.42	1.66	1.04	1.25	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	309.97	24.41	12.67	2.99	0.23	2.07	1.61	1.61	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	414.05	29.33	1.62	3.24	0.00	2.34	2.70	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	306.07	21.85	1.96	0.62	2.27	0.41	0.00	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	282.75	29.35	1.40	1.40	3.49	0.00	0.47	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	403.56	30.70	0.00	0.96	2.88	0.32	0.64	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	413.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	342.08	15.78	0.00	0.00	0.00	0.56	0.56	0.56	1.69
CD14+ Monocytes, donor2	11305-117B9	310.14	18.00	0.37	2.04	1.48	0.74	1.30	0.56	0.56
CD14+ Monocytes, donor3	11381-118B4	291.32	16.03	0.22	1.76	1.54	0.66	0.22	0.22	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1423.99	82.37	0.00	2.26	1.13	3.40	5.94	3.96	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1177.41	78.09	1.14	2.27	0.38	5.31	3.79	7.20	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1170.97	72.32	0.00	3.62	0.00	5.59	3.94	3.62	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	644.54	21.68	1.73	7.66	0.72	2.89	1.16	2.60	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	503.31	27.16	6.34	3.32	0.60	1.81	0.60	1.51	4.53
CD14+ monocytes - mock treated, donor3	11883-125D2	490.84	21.79	2.61	2.84	1.18	2.61	0.47	1.66	6.63
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	513.74	15.23	1.34	5.02	0.67	1.67	1.34	1.51	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	498.20	15.73	5.80	1.93	2.21	1.93	1.38	0.83	3.31
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	633.21	22.81	5.45	2.23	1.98	0.74	0.74	0.25	5.21
CD14+ monocytes - treated with BCG, donor1	11860-125A6	571.35	22.52	1.76	3.52	1.17	1.96	1.37	1.37	2.74
CD14+ monocytes - treated with BCG, donor2	11870-125B7	446.01	13.00	3.20	4.10	1.42	3.74	0.71	0.71	2.14
CD14+ monocytes - treated with BCG, donor3	11880-125C8	950.39	33.73	5.22	3.92	1.31	1.52	1.74	0.22	4.35
CD14+ monocytes - treated with Candida, donor1	11868-125B5	501.03	14.05	0.94	3.51	0.70	3.98	1.40	0.94	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	503.74	17.42	2.11	2.64	2.64	2.11	1.06	0.53	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	590.18	13.31	1.11	1.11	0.00	0.00	1.11	0.00	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	615.08	22.91	0.74	6.99	1.34	5.65	1.34	1.78	3.12
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	622.39	26.34	5.79	4.99	1.40	3.39	2.20	1.00	7.18
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	957.92	37.27	6.87	5.83	1.46	3.12	2.29	1.04	5.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	768.49	19.22	1.60	6.41	1.83	8.92	1.83	2.75	2.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	777.92	21.72	7.69	2.04	1.81	3.62	0.23	1.13	4.98
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	613.23	19.64	3.06	3.06	1.75	3.06	0.44	1.75	3.93
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	509.74	20.17	0.81	5.92	0.81	3.50	2.15	0.54	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	567.17	21.28	1.74	5.93	1.40	2.62	1.05	0.87	4.54
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	554.64	32.40	1.68	4.63	0.42	0.84	3.37	1.68	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	708.02	16.35	3.86	3.67	2.02	2.76	1.65	1.65	3.31
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	506.56	15.15	10.57	3.87	1.41	2.82	0.35	0.35	5.99
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	722.14	17.99	8.77	3.07	3.07	3.51	0.44	1.75	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	475.87	13.25	1.74	6.80	1.57	2.27	0.70	2.09	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	467.20	19.70	2.97	4.46	0.74	1.86	1.86	0.74	5.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	873.41	28.67	1.51	3.23	2.16	2.59	1.29	1.72	3.88
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	626.52	16.79	3.28	4.09	0.82	1.23	1.23	1.23	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	768.88	20.40	12.29	2.78	2.32	0.70	1.62	0.23	3.01
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	936.32	24.82	9.28	4.87	2.78	2.32	2.32	0.46	3.25
CD14+CD16+ Monocytes, donor1	11789-124B7	774.86	52.53	0.22	5.45	0.00	1.31	2.18	0.87	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	758.12	46.89	0.00	3.23	0.69	1.62	1.39	1.39	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	705.52	49.17	0.22	1.08	0.65	1.30	1.52	0.87	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	894.47	40.80	0.16	1.71	0.62	2.65	1.25	0.78	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	827.99	42.44	0.00	4.89	0.17	3.14	1.22	1.57	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	831.90	52.62	0.00	4.01	0.45	1.34	0.89	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	514.94	30.62	0.00	1.53	0.26	0.77	0.51	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	656.06	35.35	0.00	1.54	0.22	1.10	1.10	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	707.01	48.64	0.00	1.26	0.42	0.63	1.47	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	508.08	42.68	0.00	0.00	0.00	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	580.35	48.81	0.00	1.36	0.00	1.36	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	561.29	43.50	0.00	1.04	2.07	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	560.76	43.18	0.00	0.00	0.53	1.60	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	675.45	49.85	1.07	1.07	1.07	1.61	2.14	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	516.63	50.54	0.70	0.70	0.00	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	599.25	41.57	0.78	0.78	0.00	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	585.32	52.73	0.00	1.32	1.32	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	367.39	18.90	0.00	3.29	1.64	1.64	1.64	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	383.75	18.14	0.00	0.00	0.73	0.73	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	357.92	16.15	0.00	1.51	1.51	0.50	1.51	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	917.21	71.11	2.02	0.40	0.40	0.40	2.42	1.62	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	775.41	61.12	2.40	0.00	1.60	1.20	1.20	1.60	1.20
CD34+ Progenitors, donor1	11545-120B6	194.79	10.04	0.00	0.00	2.01	0.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	373.60	10.11	0.00	0.56	1.69	1.12	0.56	0.00	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	409.20	45.84	0.00	1.13	1.50	1.50	0.38	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	501.70	43.52	0.00	0.45	1.80	1.13	0.90	0.23	1.13
CD4+ T Cells, donor1	11225-116C1	448.82	36.06	0.36	0.71	2.50	0.36	0.71	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	336.19	20.21	0.61	3.67	2.45	0.61	1.22	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	394.36	41.17	0.30	2.44	0.91	1.83	0.61	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	575.56	85.76	0.00	2.30	0.00	2.81	1.79	1.28	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	549.59	70.97	0.00	1.12	0.22	1.35	1.35	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	510.82	76.46	0.00	2.30	0.29	2.01	1.44	1.44	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	567.01	54.52	0.00	2.37	1.42	3.79	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	581.52	61.80	0.70	0.70	0.00	1.40	2.11	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	514.21	52.74	0.00	3.30	0.00	3.30	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	682.55	82.66	0.29	3.03	0.58	2.02	1.73	1.16	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	419.76	61.85	0.00	4.07	0.68	2.54	2.88	1.02	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	400.60	61.74	0.64	3.22	1.45	1.93	2.10	1.61	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	600.72	68.59	0.00	3.14	0.00	3.14	0.90	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	668.38	73.02	0.35	3.14	0.00	2.10	0.70	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	807.37	99.00	0.00	3.96	1.76	1.76	1.76	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	680.53	77.16	0.00	3.37	0.00	3.79	2.11	2.53	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	393.72	50.28	0.21	3.95	1.04	3.32	2.08	1.66	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	402.96	51.46	0.00	4.01	0.00	1.34	2.34	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	615.93	63.90	0.00	3.54	1.09	0.82	1.90	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	657.61	65.39	0.00	0.00	0.00	2.68	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	541.55	77.11	0.00	7.17	0.00	1.79	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	768.97	102.54	0.00	2.41	1.48	1.67	0.93	1.48	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	619.53	79.50	0.43	1.52	1.08	1.30	1.73	1.52	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	560.89	91.63	0.00	3.36	1.26	3.36	1.68	2.31	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	507.12	67.75	0.00	0.51	1.52	1.01	0.51	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	615.65	58.06	0.00	0.43	0.43	1.30	0.87	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	824.13	115.49	0.00	3.49	0.00	2.18	0.44	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	723.50	85.12	0.00	3.96	1.98	0.99	0.00	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	633.31	97.86	0.00	0.92	1.85	0.00	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	647.66	85.15	0.00	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	804.20	102.46	0.00	1.38	1.66	1.11	0.55	1.66	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1048.06	141.59	0.00	4.91	2.21	2.70	0.25	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	873.18	117.04	0.00	0.00	0.00	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	810.78	98.84	0.00	2.51	1.43	2.15	1.07	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	706.35	99.72	0.00	0.00	0.00	0.00	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	503.86	35.36	0.33	1.64	3.93	1.64	0.98	1.31	0.98
CD8+ T Cells, donor2	11307-117C2	290.21	24.03	0.00	1.13	3.00	0.75	1.13	1.13	1.88
CD8+ T Cells, donor3	11383-118B6	329.75	29.29	0.25	1.77	2.27	0.50	1.01	0.76	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	396.39	74.09	42.21	3.21	9.63	0.69	5.05	1.84	5.28
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	387.74	62.55	40.74	2.64	12.46	0.96	3.59	2.40	3.12
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	419.69	64.57	48.97	6.29	8.48	3.01	6.02	2.74	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	657.46	114.98	69.65	5.70	12.91	0.90	6.90	3.30	4.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	438.21	78.71	49.20	6.96	13.20	2.64	5.76	2.16	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	457.73	73.67	47.30	4.78	9.78	2.73	2.05	1.59	3.64
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	443.48	76.27	15.64	3.48	10.65	1.30	3.69	1.96	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	439.81	78.43	16.06	5.79	10.00	2.90	5.00	1.84	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	438.78	77.16	18.53	5.39	9.62	2.11	5.39	1.88	2.11
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	483.31	85.13	13.89	5.74	7.85	2.11	9.06	3.62	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	418.62	73.79	12.78	5.52	9.59	0.29	8.42	2.32	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	426.29	87.39	13.59	4.00	9.86	1.07	3.46	1.87	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	351.95	53.41	26.70	1.31	15.32	1.75	0.44	1.31	6.13
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	375.73	60.57	35.98	5.47	12.75	0.46	3.19	0.00	4.55
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	250.61	49.23	36.55	4.48	10.44	4.48	2.24	2.98	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	433.99	79.95	39.98	3.24	9.36	2.52	5.40	0.36	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	435.03	78.26	44.60	2.30	7.77	2.30	4.03	1.73	5.18
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	385.84	61.99	34.65	2.59	12.96	2.12	2.59	1.89	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	515.60	102.68	19.01	4.12	8.24	0.95	6.34	1.27	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	406.91	88.58	14.46	5.23	14.15	1.54	5.54	3.38	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	435.99	92.97	16.03	4.81	12.18	1.28	2.56	0.96	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	424.54	86.05	15.68	3.82	10.71	1.91	3.44	1.53	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	374.01	74.88	16.95	1.97	11.43	0.79	5.91	0.79	4.34
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	353.25	71.86	8.32	2.27	9.08	0.76	7.56	0.76	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	399.87	44.16	31.32	3.21	27.30	1.61	2.41	1.61	11.24
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	386.78	36.37	23.78	4.90	30.08	2.80	2.80	2.10	10.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	420.74	65.11	24.04	6.01	32.06	1.00	1.00	1.00	14.02
Cardiac Myocyte, donor1	11525-119I4	162.67	16.45	0.00	5.48	0.00	5.48	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	300.90	27.17	0.00	0.99	0.49	0.99	3.46	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	461.97	34.83	3.37	0.74	1.47	0.11	0.32	0.11	0.84
Chondrocyte - de diff, donor1	11261-116G1	423.28	30.51	3.47	1.39	1.73	3.47	1.39	1.39	1.73
Chondrocyte - de diff, donor2	11338-117F6	331.21	26.65	1.07	1.42	0.00	0.36	1.07	1.42	0.36
Chondrocyte - de diff, donor3	11410-118E6	313.35	21.50	2.50	1.02	0.34	0.57	1.71	1.71	0.57
Chondrocyte - re diff, donor2	11339-117F7	616.83	51.03	2.69	0.00	0.90	3.58	0.00	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	259.63	19.01	0.81	0.81	0.81	1.62	2.02	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	514.46	36.38	0.46	2.30	2.64	1.15	0.92	0.69	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	291.58	29.07	0.86	1.50	0.64	0.43	1.71	1.71	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	308.86	28.50	0.09	1.06	1.59	1.42	0.97	1.06	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	987.25	54.20	0.09	2.84	3.30	2.93	2.11	2.11	14.03
Corneal Epithelial Cells, donor1	11526-119I5	418.72	33.16	4.39	1.10	0.00	0.88	0.44	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	400.44	30.72	3.41	1.14	0.00	2.28	1.14	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	357.63	35.28	2.30	1.53	0.00	1.28	1.53	1.53	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	964.32	67.03	0.83	4.29	5.12	4.46	2.48	2.15	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	987.86	82.32	0.00	2.84	5.68	5.36	0.95	2.52	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	879.93	75.92	0.00	3.45	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	583.58	49.46	0.00	4.10	3.46	3.56	2.38	2.70	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	884.85	35.19	0.00	1.71	0.68	1.71	1.37	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	788.01	52.88	0.00	0.65	0.00	1.31	1.96	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	902.07	50.81	0.00	0.48	0.97	0.97	1.94	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	330.70	24.35	0.67	0.67	1.50	1.17	0.17	2.00	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	184.83	18.78	0.00	0.00	1.76	0.00	1.17	1.17	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	300.61	28.56	0.00	0.28	2.26	0.28	0.28	0.85	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	186.37	19.27	0.00	0.39	2.36	0.79	0.39	0.00	1.57
Endothelial Cells - Artery, donor1	11264-116G4	236.77	23.85	0.00	0.29	0.87	0.00	0.58	2.62	1.16
Endothelial Cells - Artery, donor2	11341-117F9	238.10	29.17	0.00	1.41	1.65	0.71	1.41	0.94	0.71
Endothelial Cells - Artery, donor3	11413-118E9	288.56	32.08	0.00	1.40	1.58	0.88	0.35	1.40	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	391.66	30.81	0.00	1.33	1.11	0.89	1.11	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	421.71	32.56	0.00	0.61	0.61	0.61	0.00	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	441.46	25.65	0.00	0.85	1.69	0.56	0.00	0.85	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	413.02	32.39	0.00	0.59	2.08	2.08	1.19	0.89	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	297.82	29.16	0.00	1.04	0.52	2.60	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	237.49	19.99	0.14	0.57	1.56	0.85	0.57	1.42	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	420.93	33.21	0.00	2.00	3.60	3.20	0.40	1.20	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	283.03	31.45	0.00	1.05	2.62	0.52	1.57	3.14	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	467.17	45.72	0.00	2.24	1.62	1.37	0.50	1.49	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	125.79	14.34	0.00	0.22	0.65	0.22	0.00	0.22	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	155.35	19.78	0.00	0.85	1.34	0.61	0.98	0.12	1.83
Endothelial Cells - Vein, donor1	11267-116G7	141.05	12.51	0.00	0.00	3.41	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	287.08	36.32	0.00	0.00	2.10	1.40	0.70	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	201.75	17.11	0.00	0.94	0.79	1.41	0.79	0.79	1.26
Eosinophils, donor1	12244-129H3	731.85	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1107.33	64.36	0.00	1.65	0.00	4.95	3.30	0.00	1.65
Eosinophils, donor3	12246-129H5	1052.21	17.83	0.00	0.00	0.00	3.57	3.57	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	422.20	27.85	1.95	0.98	0.49	0.49	0.24	1.71	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	341.15	16.64	2.08	4.16	0.00	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	390.45	48.81	0.00	0.00	0.00	0.00	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	347.30	21.76	6.57	4.52	2.05	3.28	0.41	1.64	3.28
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	264.96	23.10	0.44	12.92	0.55	9.96	8.10	8.65	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.70	4.44	1.30	0.65	0.00	0.43	0.54	0.33	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	422.05	33.59	5.34	1.94	0.85	1.09	2.06	3.03	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	373.66	29.07	2.32	1.64	1.36	0.68	0.96	0.41	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	326.53	26.16	4.11	2.95	0.63	0.84	1.27	2.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1160.41	113.83	35.83	10.28	2.63	2.11	5.80	7.38	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	347.81	33.88	1.00	1.99	1.00	1.33	3.32	2.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	248.59	15.88	0.45	0.00	0.91	0.00	1.81	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	403.99	24.25	3.03	1.52	0.00	0.76	0.00	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	229.63	20.19	2.05	1.42	0.16	1.73	0.63	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	382.22	34.86	0.00	0.30	1.82	0.61	0.00	2.42	0.00
Fibroblast - Cardiac, donor5	11456-119A7	304.82	32.23	6.22	2.41	0.25	1.40	1.14	0.76	0.76
Fibroblast - Cardiac, donor6	11460-119B2	290.30	26.83	0.15	1.52	0.30	1.21	1.06	1.36	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	666.60	41.67	0.13	1.21	1.61	0.80	0.94	0.80	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	257.56	17.69	0.00	1.29	1.29	1.73	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	471.66	55.66	0.00	0.00	0.00	1.46	4.39	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	643.71	55.35	34.60	0.92	1.61	0.92	1.15	0.69	3.23
Fibroblast - Conjunctival, donor3	11692-122I9	527.47	33.07	0.00	2.20	0.68	2.04	0.68	1.02	0.34
Fibroblast - Dermal, donor1	11269-116G9	234.08	26.77	0.00	1.64	0.00	1.17	1.41	3.99	0.70
Fibroblast - Dermal, donor2	11346-117G5	370.74	41.51	1.42	1.42	0.00	0.94	0.47	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	306.33	22.61	0.48	1.69	0.48	1.69	1.45	2.54	0.36
Fibroblast - Dermal, donor4	11450-119A1	317.09	33.69	1.81	2.03	0.90	0.90	1.13	1.81	1.36
Fibroblast - Dermal, donor5	11454-119A5	330.24	28.44	3.31	3.14	1.57	1.40	1.74	1.40	1.74
Fibroblast - Dermal, donor6	11458-119A9	368.86	39.63	0.16	3.25	0.81	1.30	1.14	0.97	0.97
Fibroblast - Gingival, donor1	11237-116D4	502.04	30.19	1.87	0.83	0.21	0.83	0.62	1.04	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	349.25	33.01	1.31	1.83	1.05	3.67	1.05	2.62	0.26
Fibroblast - Gingival, donor2	11318-117D4	423.03	25.96	0.13	2.50	0.40	0.66	2.37	1.45	0.40
Fibroblast - Gingival, donor3	11394-118C8	334.34	25.53	5.70	1.26	0.77	1.26	0.10	0.87	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	462.31	28.05	0.00	2.08	0.00	3.12	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	249.86	15.51	1.06	1.94	0.35	1.23	1.76	1.76	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	462.54	39.29	0.00	0.94	1.09	1.56	1.56	1.56	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	457.20	34.48	0.00	2.16	0.54	1.22	1.35	1.76	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	298.54	29.64	0.00	0.00	1.06	0.71	1.41	0.71	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	341.33	30.71	0.00	2.19	0.15	1.61	2.34	0.58	1.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	446.15	34.77	0.00	1.36	1.36	0.82	1.23	1.64	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	370.43	30.82	1.10	1.10	1.21	1.32	1.86	0.77	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	378.73	23.33	2.49	1.32	0.73	2.20	2.79	1.32	0.59
Fibroblast - Lung, donor1	11270-116H1	205.26	28.55	1.36	1.36	1.36	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	392.44	37.30	1.49	1.49	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	331.75	30.18	0.00	2.95	0.84	0.84	3.17	1.69	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	810.53	71.64	2.50	0.83	3.33	1.67	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	283.92	30.77	0.00	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	168.21	17.63	1.40	0.28	0.56	0.28	0.00	0.28	1.40
Fibroblast - Mammary, donor1	11540-120B1	833.86	82.01	3.25	0.81	2.03	1.22	0.00	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	303.56	23.97	7.99	0.00	3.99	3.99	3.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	369.29	17.87	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	517.13	37.82	0.39	1.16	0.78	0.58	1.16	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	362.67	31.40	0.30	1.97	0.46	0.15	1.06	1.21	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	478.56	37.94	1.22	1.22	0.92	1.22	0.00	0.31	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	236.99	24.42	1.53	0.38	2.29	1.14	0.76	0.00	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	369.89	28.62	0.81	2.43	0.27	1.89	2.43	1.35	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	265.12	22.04	0.58	1.16	1.51	1.39	1.04	0.46	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	486.01	41.23	0.55	0.99	0.99	0.55	0.88	0.77	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	795.29	62.58	3.05	1.22	1.83	1.22	0.00	0.20	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	334.10	34.75	1.34	0.00	2.00	0.67	0.67	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	303.24	26.49	0.40	0.79	1.58	0.40	1.19	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	719.97	62.51	2.98	2.58	2.18	2.18	1.19	1.39	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	561.10	30.91	1.78	2.13	0.89	1.07	1.24	1.60	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	560.90	37.84	3.15	1.97	0.39	1.97	0.79	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	935.66	100.49	6.62	5.72	0.30	2.41	1.20	1.20	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	573.76	39.73	1.62	2.27	0.97	0.76	1.51	1.73	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	487.42	42.52	4.05	1.52	1.77	0.76	1.01	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	622.35	49.22	2.13	1.31	0.33	1.31	0.49	0.98	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1119.83	102.46	14.44	2.21	2.61	3.01	0.40	1.20	1.00
Fibroblast - skin normal, donor2	11561-120D4	539.28	49.23	5.42	2.41	1.21	0.90	0.90	1.41	1.41
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	526.50	55.31	4.53	0.91	1.81	0.60	1.81	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	533.20	26.01	1.82	1.49	0.50	1.33	0.66	0.66	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	592.00	31.28	0.00	2.39	0.51	1.54	1.37	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	921.91	85.06	4.60	3.94	1.64	2.63	2.30	1.64	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	605.58	51.45	1.38	2.34	0.85	0.85	1.28	2.66	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	544.33	51.11	0.67	1.01	0.67	1.01	0.67	1.01	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	861.10	71.98	5.02	12.55	1.10	3.45	10.66	8.94	2.67
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1529.03	155.12	0.00	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	224.85	14.82	0.00	0.00	0.00	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	584.56	32.76	0.17	1.73	0.87	2.77	0.35	1.21	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	557.18	38.52	0.52	1.30	0.00	3.12	0.78	1.04	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	398.60	28.36	0.51	0.77	0.51	2.04	0.26	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	443.25	30.62	0.00	6.12	6.12	6.89	4.59	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	573.63	47.86	0.00	7.02	1.91	6.38	2.55	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	525.74	39.65	0.00	3.71	2.85	4.28	5.13	4.85	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	432.66	34.47	0.00	8.00	2.48	19.58	7.45	7.17	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	310.07	16.67	0.46	2.97	2.74	15.30	4.79	2.74	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	382.00	29.72	0.20	4.56	2.77	7.73	5.55	4.95	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	397.56	27.49	0.00	6.34	2.11	19.83	7.93	5.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	309.19	17.94	1.30	4.89	2.61	14.35	3.26	3.26	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	516.96	45.99	0.88	4.42	3.98	2.65	3.54	2.21	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	608.68	39.99	0.14	3.39	4.38	1.98	1.13	1.41	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	437.28	33.37	0.37	2.83	3.45	1.97	1.48	0.86	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	471.97	39.76	0.00	4.57	3.76	1.61	2.15	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	539.68	26.27	0.12	2.73	2.23	2.11	1.73	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	612.26	39.04	0.14	4.43	4.57	1.66	1.94	1.66	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	558.88	43.10	0.81	4.68	3.66	3.05	2.03	2.24	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	418.94	27.61	0.46	1.37	2.74	2.74	1.37	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	515.08	31.02	0.25	2.37	1.62	1.99	2.12	1.87	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	408.30	31.48	0.00	1.97	2.62	0.66	1.75	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	467.45	23.34	0.59	2.95	3.84	2.36	1.77	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	545.39	27.02	0.00	3.18	2.38	1.75	1.27	2.07	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	492.86	35.97	0.22	2.01	2.90	2.01	0.67	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	410.53	21.78	0.00	1.61	1.21	2.62	1.41	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	608.34	27.48	0.00	3.22	2.88	2.37	1.53	2.21	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	767.10	41.32	0.35	2.57	3.46	2.48	0.89	0.27	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	577.41	24.77	0.10	0.94	2.08	1.14	0.21	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	573.98	29.03	0.00	1.37	3.07	1.20	0.17	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	439.07	21.25	0.00	1.55	1.88	1.11	1.00	1.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	728.05	37.27	0.42	1.91	2.00	1.25	0.75	0.75	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	774.46	37.57	0.20	1.23	1.23	4.08	0.82	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	440.46	22.90	0.21	1.65	2.06	2.06	1.24	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	479.27	21.68	0.00	1.96	1.38	1.27	1.38	0.92	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	421.58	23.68	0.17	2.33	1.67	2.00	2.17	0.83	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	367.90	19.18	0.00	0.88	2.42	1.54	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	520.38	24.84	0.12	2.34	1.11	1.84	1.72	1.72	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	448.02	25.93	0.65	1.13	1.78	1.13	1.30	0.97	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	436.49	19.24	0.64	1.92	0.64	1.92	0.96	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	424.69	26.72	0.28	1.52	1.71	1.23	1.90	0.85	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	380.26	21.51	0.00	1.74	0.95	1.58	1.42	0.95	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	423.90	23.72	0.00	2.13	3.34	2.13	1.22	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	452.96	20.70	0.10	2.61	1.57	2.20	1.78	1.15	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	429.45	21.74	0.00	2.20	1.32	0.44	2.20	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	397.54	22.16	0.00	3.37	1.96	1.12	1.68	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	368.03	18.52	0.00	1.76	0.83	1.11	0.83	0.65	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	472.77	28.34	0.27	1.87	3.74	1.60	2.67	1.60	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	367.98	23.41	0.00	1.84	1.68	0.92	0.77	1.38	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	414.39	21.89	0.00	1.81	1.17	0.91	1.30	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	378.96	31.72	0.00	2.17	1.63	1.36	1.36	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	377.18	20.46	0.18	0.74	2.03	0.92	1.29	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	392.13	23.03	0.00	2.41	1.54	0.88	1.10	1.97	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	353.06	29.75	0.00	0.00	4.96	1.98	0.99	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	347.46	21.37	0.13	1.19	0.92	0.79	0.66	0.40	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	365.58	19.37	0.00	2.62	1.01	1.41	1.82	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	925.40	54.64	0.00	0.76	7.88	1.02	0.00	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	613.30	51.76	0.00	2.99	4.98	3.18	2.39	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	461.00	34.05	0.00	3.24	3.39	2.77	1.23	1.85	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	472.59	31.91	0.00	1.84	3.48	0.61	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	516.65	35.99	0.00	2.82	3.13	4.38	1.88	1.88	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	446.72	28.82	0.00	1.70	5.37	1.70	1.13	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	412.32	32.75	0.46	2.77	5.07	1.84	1.84	2.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	376.17	29.70	0.00	4.95	0.00	2.47	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	538.82	34.81	0.39	4.25	2.32	1.93	7.35	3.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	426.79	36.90	0.00	9.63	4.81	8.02	6.42	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	495.57	24.34	0.00	10.43	3.48	3.48	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	540.62	30.27	0.00	3.91	2.60	3.91	4.56	2.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	536.17	35.83	0.00	2.06	3.71	5.35	5.77	3.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	319.90	33.32	0.00	19.99	3.33	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	526.02	27.13	0.00	3.36	2.52	2.80	6.15	3.64	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	571.65	29.74	0.00	6.21	1.63	2.29	4.58	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	402.64	17.62	0.00	9.23	0.84	5.87	4.19	3.36	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	541.68	32.76	0.00	2.54	1.59	2.54	4.13	4.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	568.59	27.17	0.00	4.42	2.38	3.40	6.45	2.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	490.71	27.15	0.00	6.26	2.09	2.09	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	532.04	28.63	0.00	5.73	0.57	2.29	6.87	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	501.69	20.42	0.00	5.33	0.59	3.26	6.22	2.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	428.62	33.88	0.00	5.08	3.39	1.69	5.08	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	655.28	32.31	0.41	4.97	2.49	1.66	5.38	5.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	551.39	34.06	0.00	3.91	3.22	2.99	4.83	3.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	505.78	21.07	0.00	0.00	0.00	10.54	15.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	474.36	22.68	0.00	5.00	1.54	3.08	5.77	2.69	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	498.41	22.82	0.00	2.93	1.63	2.61	4.89	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	323.05	12.04	0.00	5.35	0.67	2.01	6.69	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	572.12	21.19	0.00	6.16	0.77	5.01	5.39	3.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	605.26	18.49	0.00	5.82	2.40	4.45	5.48	3.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	362.78	12.42	0.00	7.45	2.48	4.97	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	444.95	12.74	0.94	6.13	0.47	5.19	6.13	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	497.28	19.92	0.00	4.22	4.22	6.03	3.02	3.62	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	456.28	12.21	0.00	3.05	1.02	3.05	4.58	3.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	515.70	25.53	0.00	5.98	0.40	3.59	7.18	4.79	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	516.54	19.73	0.00	5.43	0.99	3.45	6.41	4.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	479.26	20.07	0.00	5.90	2.36	4.72	9.44	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	493.01	18.67	0.00	8.17	0.00	1.75	8.75	4.08	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	541.58	21.51	0.00	3.95	1.76	3.95	3.95	4.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	426.39	21.19	0.00	3.39	2.54	2.54	5.93	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	421.42	19.10	0.00	4.18	2.39	1.79	1.79	2.98	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	473.60	27.66	0.49	6.79	2.91	0.97	9.70	2.43	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	354.95	35.38	0.00	0.00	1.14	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	253.23	21.62	0.00	1.25	0.42	1.25	0.83	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	347.46	29.24	0.00	3.37	2.25	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	372.98	22.84	0.00	2.54	0.32	0.00	2.85	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	347.56	31.33	0.00	1.25	1.25	0.84	1.25	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	495.15	49.32	0.00	2.55	0.58	1.04	2.09	2.09	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	529.70	52.50	0.00	2.53	1.01	1.69	2.53	1.18	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	531.22	54.15	0.46	1.37	0.91	0.91	1.82	1.37	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	514.30	47.22	0.55	2.84	1.53	1.97	2.95	2.08	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	496.66	51.79	0.43	1.72	2.15	2.15	1.93	1.07	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	514.74	46.93	0.86	1.08	1.72	1.51	0.43	0.86	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	546.47	46.08	0.25	2.37	0.37	1.74	1.87	0.87	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	513.79	48.55	0.34	1.37	1.37	1.20	2.06	1.03	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	506.51	47.42	1.28	2.88	0.64	1.92	1.28	1.60	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	313.39	35.26	0.00	0.56	4.48	2.24	0.56	1.12	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	258.38	23.37	0.43	0.87	0.87	0.00	0.00	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	253.81	26.44	0.00	0.00	0.00	5.29	5.29	7.93	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	425.73	38.80	0.00	1.41	0.00	1.06	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	252.10	30.51	0.00	2.18	0.73	1.45	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	366.11	38.64	3.15	1.92	1.05	1.22	2.10	0.87	1.57
Hepatocyte, donor1	11523-119I2	1858.28	56.90	0.00	21.79	1.21	16.95	23.00	12.11	9.68
Hepatocyte, donor2	11603-120I1	1913.35	63.56	1.08	20.47	0.00	16.16	24.78	8.62	7.54
Hepatocyte, donor3	11684-122I1	932.58	52.76	1.84	4.29	0.00	10.43	6.14	2.45	6.75
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	362.24	26.11	11.10	1.96	9.79	0.00	1.31	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	1549.26	48.59	3.85	3.15	3.15	3.67	2.80	5.77	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	427.12	40.89	0.27	1.10	0.69	0.82	0.55	0.55	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	95.52	9.55	0.00	6.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	20.03	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	127.36	16.61	0.00	0.00	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	210.22	22.52	12.51	2.50	7.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	261.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	112.77	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	164.55	32.00	18.28	0.00	0.00	0.00	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	167.31	16.24	0.00	1.62	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	170.07	18.34	0.00	3.33	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	214.20	32.68	7.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	148.23	19.85	0.00	0.00	2.65	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	169.62	19.96	0.00	0.00	3.33	0.00	0.00	1.11	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	167.63	20.95	5.24	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	195.89	12.60	0.63	0.63	1.26	1.26	0.63	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	170.13	15.47	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	163.45	18.74	0.00	1.29	1.29	0.00	0.00	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	138.45	11.27	0.00	1.61	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00	11.95	11.95	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	189.05	19.56	0.81	0.81	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	172.12	19.31	0.00	0.00	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	172.47	28.74	0.00	0.00	14.37	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	180.83	14.47	0.00	0.80	0.00	0.80	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	151.42	21.24	0.00	0.00	3.69	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	236.96	24.55	0.94	1.42	1.42	1.42	0.47	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	174.14	23.58	0.00	3.63	2.72	0.91	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	195.85	19.37	0.00	1.08	1.08	1.08	1.08	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	160.08	19.06	0.00	1.27	0.00	0.00	0.00	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	16.43	16.43	16.43	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	144.75	10.84	0.64	1.28	1.91	0.00	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	120.30	10.94	0.00	0.00	1.82	1.82	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	147.10	13.57	0.00	0.00	0.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	96.23	13.27	0.00	0.00	0.00	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	243.84	17.28	0.31	2.78	0.93	0.62	0.62	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	124.68	29.85	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	157.16	9.43	3.14	3.14	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	106.39	9.04	0.00	0.70	0.70	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	101.80	13.28	8.85	0.00	2.21	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	142.65	22.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	159.56	12.21	6.10	0.87	1.74	0.00	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	157.48	15.75	9.00	2.25	0.00	0.00	0.00	2.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	6.97	20.91	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	194.15	18.14	9.60	0.00	4.27	0.00	1.07	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	123.30	12.47	2.77	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	96.89	11.40	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	162.92	16.57	1.84	0.92	0.92	0.00	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	190.60	15.13	33.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	204.89	31.04	37.25	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	169.18	8.46	25.38	0.00	3.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	483.31	25.38	1.31	1.71	0.57	2.04	0.73	2.28	0.08
Keratinocyte - epidermal, donor2	11349-117G8	305.70	20.50	9.96	0.59	0.59	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	389.04	27.64	3.69	1.89	0.38	0.85	1.04	1.51	0.00
Keratinocyte - oral, donor1	11251-116E9	599.37	36.89	3.06	2.16	0.91	1.14	1.25	0.68	0.57
Keratocytes, donor1	11527-119I6	765.71	55.36	18.91	1.03	2.06	0.69	0.00	1.03	2.41
Keratocytes, donor2	11607-120I5	339.82	46.87	4.69	1.17	2.34	2.34	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	361.80	16.20	5.73	0.99	0.79	1.38	0.79	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	265.95	4.40	2.20	0.00	4.40	2.20	2.20	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	309.60	44.23	0.00	2.16	0.00	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	559.48	30.10	0.00	1.50	1.38	0.69	0.81	1.27	0.00
Lens Epithelial Cells, donor3	11690-122I7	324.22	33.60	2.93	0.10	1.61	0.30	0.30	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	373.75	28.22	0.00	1.30	1.54	1.78	0.47	2.02	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	246.98	18.98	0.00	1.95	1.40	1.67	1.40	1.12	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	283.66	19.20	0.00	1.73	0.47	1.57	1.10	0.94	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	310.80	20.97	0.00	1.08	1.61	0.54	1.08	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	226.29	17.33	0.00	0.63	1.26	2.21	0.32	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	247.87	17.57	0.00	1.83	0.97	1.19	1.51	1.40	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	300.41	22.57	0.00	1.64	1.23	0.00	1.64	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	284.42	16.94	0.00	1.26	1.01	0.00	2.02	0.76	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	269.40	17.88	0.00	1.27	1.13	0.56	1.97	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	296.65	22.55	0.00	0.79	1.98	1.58	0.40	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	292.38	20.36	0.00	0.97	0.39	2.13	1.55	0.97	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	247.54	17.03	0.00	1.11	1.11	1.11	0.19	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	311.14	25.43	0.00	1.05	0.35	1.05	0.70	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	293.62	22.42	0.00	1.19	0.72	1.43	1.67	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	259.18	20.74	0.00	1.37	0.41	0.69	1.24	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	292.56	27.72	0.00	0.92	0.62	0.62	0.62	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	242.54	14.03	0.00	0.62	0.94	0.94	1.25	1.56	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	293.15	21.59	0.00	1.28	1.46	0.73	0.37	0.73	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	276.12	28.63	0.00	1.32	0.99	0.99	0.99	0.33	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	268.27	19.92	0.29	2.34	0.59	0.88	1.17	0.88	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	283.53	19.91	0.00	1.49	0.50	1.74	1.00	1.99	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	272.55	28.61	0.00	0.97	0.97	0.48	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	283.84	21.54	0.00	0.27	0.00	1.08	0.54	1.35	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	273.09	19.07	0.00	1.67	1.21	1.06	2.57	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	286.16	20.74	0.00	1.56	1.56	1.04	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	279.96	20.94	0.00	1.47	1.05	0.63	1.88	1.05	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	285.41	21.65	0.00	1.20	0.90	0.60	1.95	1.35	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	295.10	26.14	0.00	0.69	1.38	2.06	3.44	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	264.35	21.83	0.00	1.51	0.56	0.94	2.07	0.56	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	242.49	16.12	0.00	1.48	0.95	0.64	1.38	1.06	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	287.35	19.38	0.00	1.45	3.39	1.94	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	263.31	18.19	0.00	1.32	2.98	0.66	2.65	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	258.93	17.10	0.00	1.86	1.61	0.99	1.36	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	295.06	20.36	0.00	0.37	0.74	0.37	1.85	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	280.69	19.03	0.00	0.74	0.49	0.74	0.99	0.49	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	255.19	15.54	0.00	1.37	0.55	0.55	1.37	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	264.39	22.51	0.00	0.96	1.29	0.64	0.96	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	311.33	20.09	0.00	3.04	1.83	1.83	1.22	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	302.89	21.83	0.00	2.24	0.84	1.12	1.12	0.98	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	299.74	18.13	0.00	2.84	1.42	0.71	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	288.44	22.30	0.00	1.45	2.42	0.00	1.45	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	251.62	18.83	0.00	1.24	1.09	1.40	0.93	0.78	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	275.02	27.22	0.00	0.00	0.72	1.07	2.15	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	278.65	17.64	0.00	0.33	0.65	1.31	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	270.50	17.42	0.00	1.41	0.47	0.94	0.24	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	373.48	29.45	0.00	1.24	1.61	0.99	0.99	0.74	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	252.29	16.39	0.00	1.02	2.31	0.77	0.51	1.02	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	231.82	20.29	0.00	0.60	2.09	0.30	1.49	0.90	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	636.75	29.46	0.00	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	577.65	36.82	0.77	3.07	0.00	2.30	2.30	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	584.88	33.40	0.00	1.48	0.74	0.74	2.97	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	541.60	23.70	0.00	4.65	2.12	3.81	2.96	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	502.88	35.87	0.00	4.22	1.41	0.70	2.81	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	505.28	26.15	0.93	3.74	0.93	0.00	2.80	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	524.54	26.79	0.00	6.70	0.52	1.03	1.55	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	457.94	27.36	0.00	2.38	1.19	2.38	4.76	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	662.07	33.48	0.23	0.00	0.68	0.68	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	762.84	40.13	0.29	11.05	0.87	2.62	5.23	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	650.95	39.62	0.45	5.85	0.00	2.70	3.60	3.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	715.77	34.14	0.27	2.30	0.68	1.22	1.22	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	572.07	27.73	0.00	6.68	0.51	1.03	4.62	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	697.95	47.99	0.35	3.88	0.00	0.35	4.23	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	716.28	50.64	0.67	1.33	2.00	2.00	4.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	534.86	29.54	0.00	6.62	0.51	1.53	5.09	3.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	719.84	37.89	0.00	5.87	0.53	2.40	4.54	1.60	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	776.00	40.43	0.00	6.24	0.94	1.32	4.72	4.16	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	565.09	25.16	0.61	5.52	0.00	2.45	7.98	4.29	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	542.26	35.06	0.00	5.71	0.82	1.63	0.00	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	705.11	37.28	0.00	9.16	0.42	2.50	3.75	3.75	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	799.86	40.64	0.28	15.97	0.84	4.48	9.25	4.20	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	556.38	24.73	0.00	5.15	2.06	1.03	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	691.21	39.77	0.58	14.81	0.87	5.52	8.71	6.68	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	711.15	34.68	0.00	3.89	0.90	2.39	3.29	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	666.67	45.92	0.00	4.98	1.11	3.32	1.11	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	509.73	26.51	0.35	7.42	1.06	0.71	3.53	2.83	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	655.69	36.88	0.37	5.90	1.48	0.74	5.90	2.95	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	488.14	23.03	0.00	3.45	0.00	1.15	3.45	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	609.40	40.29	0.00	4.22	0.38	0.77	2.69	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	550.28	22.08	0.00	13.59	0.00	6.23	4.53	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	576.79	32.00	0.00	3.28	0.82	0.82	0.00	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	522.83	29.37	0.45	4.97	0.00	0.90	1.81	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	636.28	22.26	0.00	5.75	0.72	2.15	3.59	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	627.40	44.07	0.00	5.98	0.00	2.24	2.24	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	517.26	28.98	0.00	8.55	0.00	1.49	3.72	4.09	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	740.89	36.61	0.43	9.48	1.29	2.15	3.45	1.72	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	566.01	30.83	0.00	1.71	0.00	3.43	1.71	3.43	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	708.33	35.98	0.67	6.00	0.33	5.33	3.00	5.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	688.98	34.99	0.00	6.03	0.00	3.62	4.22	2.41	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	534.67	34.84	0.71	3.55	2.13	1.42	1.42	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	631.75	38.15	0.00	3.09	1.03	2.41	3.44	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	660.74	34.35	0.00	8.05	0.54	1.61	4.83	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	474.72	30.30	0.00	4.71	1.35	0.00	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	621.54	32.60	0.00	8.52	0.37	2.96	7.41	2.96	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	776.84	24.42	1.16	0.00	1.16	3.49	3.49	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	513.01	30.67	0.00	3.17	0.00	0.00	3.17	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	555.81	34.01	0.40	5.20	0.80	3.20	4.00	3.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	397.60	24.71	0.00	1.45	0.00	0.00	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	474.47	28.36	0.00	2.30	0.00	0.00	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	506.60	33.54	0.00	5.92	0.49	2.47	6.41	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	505.28	19.76	0.00	1.88	0.94	3.76	3.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	452.54	26.15	0.00	3.52	0.00	1.01	3.02	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	488.93	28.84	0.00	6.76	0.45	0.90	4.51	2.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	531.82	12.05	0.00	3.44	0.00	1.72	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	510.81	27.17	0.45	7.13	0.89	1.78	4.45	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	512.63	30.89	0.00	6.26	1.17	1.96	5.87	1.56	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	564.07	32.33	0.00	7.26	1.98	1.32	0.66	3.30	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	605.59	42.55	0.52	6.75	1.56	1.56	1.56	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	511.52	25.82	0.00	5.69	0.88	2.19	5.69	2.19	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	598.24	27.40	0.56	5.03	0.56	2.80	1.12	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	586.06	35.33	0.00	5.30	0.00	1.77	3.53	1.77	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	598.24	30.09	0.00	6.17	0.77	1.16	5.79	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	620.79	31.39	0.00	6.58	0.00	1.01	7.09	1.52	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	562.81	31.24	0.00	4.81	1.44	1.44	2.40	1.92	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	612.22	29.82	0.40	4.77	0.00	1.99	3.98	2.78	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	631.93	38.89	0.00	6.08	0.61	1.82	2.43	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	524.31	32.51	0.00	2.08	0.69	2.08	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	558.97	34.20	0.00	5.70	0.38	2.66	5.70	1.90	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	642.42	25.82	0.00	6.20	0.00	0.52	5.68	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	429.31	22.37	0.00	1.21	1.21	0.60	2.42	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	567.89	29.47	0.00	7.92	0.32	1.58	2.54	3.49	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	420.61	16.53	0.00	2.67	1.07	1.07	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	414.91	25.86	0.57	1.72	2.30	1.72	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	454.58	26.74	0.00	6.17	1.03	1.03	3.60	2.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	531.22	29.71	0.00	3.54	0.71	1.41	2.12	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	476.12	33.48	0.00	2.27	0.57	2.27	2.27	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	508.80	30.79	0.00	3.74	1.25	2.08	3.74	2.91	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	548.13	28.97	0.78	7.83	1.57	2.35	4.70	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	567.45	31.73	0.42	1.67	1.25	0.84	0.84	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	525.51	30.20	0.00	6.50	0.93	1.86	0.46	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	578.06	24.09	0.00	2.68	0.00	2.01	2.68	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	587.04	37.42	0.00	5.35	1.07	1.60	1.60	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	500.67	29.50	0.00	4.04	1.21	2.02	2.02	3.23	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	463.47	27.53	0.00	3.67	0.00	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	521.02	16.00	0.00	0.00	0.00	0.89	4.45	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	515.73	29.06	0.00	1.14	1.71	1.71	3.42	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	501.55	21.47	0.00	5.37	0.77	1.53	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	646.76	27.91	0.55	2.74	2.19	2.19	1.09	2.19	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	494.89	29.40	0.45	3.12	0.00	0.00	2.67	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	690.70	34.31	0.00	1.56	1.30	1.04	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	576.90	26.52	0.66	4.64	1.33	1.99	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	513.42	22.86	2.08	8.31	0.00	4.16	2.08	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	873.14	61.77	0.00	2.96	0.46	3.19	0.68	2.05	0.23
Macrophage - monocyte derived, donor2	11313-117C8	786.33	69.73	0.18	1.10	2.94	2.57	0.18	0.92	0.73
Macrophage - monocyte derived, donor3	11389-118C3	594.98	54.01	0.00	3.01	2.23	3.67	2.36	1.44	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	577.22	32.39	0.00	0.53	0.00	0.00	0.53	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	821.42	54.51	0.16	1.74	0.63	1.27	1.58	1.11	0.63
Mallassez-derived cells, donor3	11930-125I4	714.40	52.95	0.69	1.39	0.42	0.83	1.25	1.95	0.00
Mammary Epithelial Cell, donor1	11273-116H4	619.58	53.71	10.56	0.90	0.80	1.59	1.30	0.80	1.00
Mammary Epithelial Cell, donor2	11350-117G9	609.50	51.25	6.37	0.58	1.16	2.03	1.16	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	264.89	18.71	1.00	0.75	0.25	0.75	0.50	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	697.60	41.35	1.36	0.68	33.90	1.36	0.00	0.00	4.75
Mast cell, donor1	11563-120D6	572.39	46.28	0.43	2.49	3.57	2.16	0.87	0.76	0.97
Mast cell, donor2	11565-120D8	361.96	27.04	0.59	1.49	2.38	1.19	0.89	0.89	4.46
Mast cell, donor3	11566-120D9	345.12	25.89	0.00	1.58	0.68	2.70	1.35	0.23	3.38
Mast cell, donor4	11567-120E1	377.27	32.44	0.00	1.24	1.06	1.42	0.89	0.89	3.55
Mast cell, expanded and stimulated, donor5	11940-126A5	753.41	81.06	1.77	3.22	4.55	2.55	1.22	0.67	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	689.33	49.61	4.09	1.75	36.19	7.00	3.50	0.00	6.42
Mast cell, expanded, donor5	11939-126A4	675.14	53.12	0.00	2.98	0.92	2.75	3.67	1.72	0.46
Mast cell, expanded, donor8	11941-126A6	606.20	46.86	0.33	3.51	1.67	6.86	2.34	2.01	2.18
Melanocyte - dark, donor1	11502-119F8	482.47	33.93	0.00	1.09	1.19	1.59	0.70	0.50	0.10
Melanocyte - dark, donor2	11582-120F7	357.16	25.96	0.00	3.46	0.69	1.04	1.04	1.04	0.69
Melanocyte - dark, donor3	11663-122F7	502.23	44.41	0.22	0.72	1.09	0.65	0.29	0.58	0.51
Melanocyte - light, donor1	11274-116H5	329.81	25.15	0.24	1.41	1.18	0.71	0.71	2.59	0.47
Melanocyte - light, donor2	11351-117H1	380.82	38.90	0.00	0.00	0.68	1.36	1.36	1.36	0.00
Melanocyte - light, donor3	11423-118G1	247.16	15.61	0.00	1.73	0.00	1.73	1.73	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	525.21	34.26	0.00	3.02	0.42	1.98	2.19	1.25	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	520.40	42.49	0.00	3.23	0.81	1.88	2.15	1.34	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	502.23	41.25	0.00	2.14	0.00	1.61	1.61	2.68	0.00
Meningeal Cells, donor1	11493-119E8	659.63	59.80	0.74	1.12	3.35	0.62	0.25	0.37	1.36
Meningeal Cells, donor2	11573-120E7	426.94	44.45	0.44	1.76	3.08	0.88	1.32	0.00	0.44
Meningeal Cells, donor3	11654-122E7	533.51	39.69	0.00	1.39	2.69	0.65	0.73	0.65	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	507.58	52.75	0.00	0.86	1.71	1.43	0.86	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	339.94	23.35	0.81	1.71	1.51	0.91	0.50	0.81	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	131.42	9.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	210.61	24.86	0.00	1.31	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	400.42	30.14	0.72	3.59	0.72	2.15	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	497.66	38.54	0.64	1.27	0.64	1.69	1.27	1.06	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	389.05	45.74	0.00	2.51	0.00	1.01	1.51	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	548.72	59.55	0.00	1.10	2.20	0.66	0.44	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	338.26	43.84	0.00	2.19	2.92	0.73	0.73	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	303.22	36.01	0.00	1.02	1.02	0.82	0.20	0.61	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	604.58	44.88	0.14	1.66	0.97	1.11	0.83	0.69	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	344.22	23.05	0.00	0.37	0.74	1.12	0.74	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	663.79	29.21	2.63	1.97	0.39	2.11	1.45	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	319.59	23.74	0.59	0.30	1.19	0.59	0.59	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	144.80	9.34	11.68	2.34	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	292.02	31.38	0.00	0.64	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	572.43	61.67	0.00	1.42	1.42	0.71	0.35	1.42	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	559.46	27.52	1.25	1.56	0.31	0.94	0.94	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	309.87	39.19	0.00	0.73	1.45	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	735.33	50.65	1.86	2.12	0.80	3.71	3.18	6.10	1.06
Mesothelial Cells, donor2	12156-128G5	449.92	32.53	2.50	0.50	1.50	1.00	0.00	0.00	2.50
Mesothelial Cells, donor3	11402-118D7	482.58	40.90	0.22	2.82	0.94	1.45	1.37	1.88	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	166.09	9.45	0.00	0.00	4.05	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	483.44	40.88	0.74	4.93	4.43	1.72	0.99	2.22	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	490.27	51.24	0.00	3.53	9.13	2.06	2.06	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	76.06	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	426.18	32.85	0.93	4.03	4.03	3.41	0.93	1.55	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	546.79	47.29	0.00	1.87	5.60	1.66	1.24	1.87	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	46.32	4.63	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	585.11	47.30	0.75	5.51	4.25	2.50	1.00	2.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	418.93	39.10	0.00	0.93	3.26	4.19	0.47	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	535.07	43.49	0.41	2.03	3.86	1.83	3.05	1.83	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	467.63	35.64	0.40	1.98	4.75	1.98	1.58	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	664.59	57.52	0.88	1.77	1.77	0.00	3.54	3.54	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	754.56	68.77	0.00	4.56	5.70	2.28	3.04	3.42	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	5.26	0.00	0.00	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	587.65	43.93	1.06	4.67	5.31	1.49	1.27	1.91	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	125.23	11.97	0.00	1.84	3.68	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	393.14	36.06	0.89	0.60	2.68	1.19	1.79	1.19	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	6.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	594.89	42.40	1.25	5.77	2.51	2.51	1.76	2.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	442.30	34.70	0.24	1.90	4.04	1.66	1.19	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	74.64	4.98	0.00	0.55	1.11	0.55	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	607.85	46.97	1.15	4.37	4.84	1.38	1.84	1.61	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	471.58	48.17	0.42	1.89	6.52	1.05	1.68	0.84	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	382.59	25.89	0.00	2.04	2.45	0.41	0.61	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	618.73	42.05	1.29	3.22	3.43	1.50	2.15	1.50	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	377.23	34.90	0.00	2.00	4.67	1.78	1.11	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	482.71	37.89	1.10	3.29	3.72	2.19	0.66	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	182.50	19.77	0.00	0.51	3.55	1.01	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	4.97	0.00	0.00	1.66	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	347.62	30.71	1.36	2.45	3.26	0.82	1.36	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	364.66	32.94	0.00	0.29	7.06	1.18	1.76	0.88	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	47.97	2.18	0.00	0.00	4.36	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	622.32	46.61	0.48	2.88	4.32	0.96	1.44	0.96	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	453.46	39.62	0.00	4.40	6.40	2.80	0.40	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	60.33	6.86	0.00	0.00	4.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	616.71	41.05	0.50	5.51	1.50	3.00	1.50	3.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	781.47	0.00	0.00	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	2.04	0.00	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	585.50	48.61	0.00	3.07	3.50	3.07	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	52.98	5.52	0.00	0.00	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	52.51	1.28	0.00	0.00	1.92	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	695.16	49.34	1.49	3.72	3.72	2.73	3.22	1.49	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	89.77	11.13	0.00	0.70	3.48	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	742.90	51.97	2.05	3.08	5.13	0.68	3.42	1.71	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	94.09	9.63	0.00	0.88	4.38	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	64.63	5.33	0.00	0.00	0.71	0.71	0.36	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	714.28	52.46	1.12	5.33	3.37	1.96	1.96	1.96	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	181.63	19.12	0.00	0.42	3.74	0.00	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	58.86	6.41	0.00	1.17	2.91	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	489.30	33.48	0.60	3.02	2.41	1.81	1.51	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	424.07	39.23	0.00	3.34	4.17	5.01	0.42	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	304.77	24.01	0.92	3.69	0.92	1.85	3.69	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	316.43	37.56	0.00	1.14	6.26	1.14	1.71	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	226.48	14.23	0.00	1.38	2.21	0.55	0.41	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	575.57	38.35	1.04	3.37	4.15	1.81	0.78	1.55	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	280.55	27.03	0.00	0.43	3.00	0.43	0.86	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	45.10	3.81	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	222.32	14.41	0.53	1.07	2.67	0.53	0.53	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	503.17	48.79	1.20	2.39	4.49	2.69	0.90	2.99	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	195.35	13.70	0.00	0.71	0.99	0.28	0.14	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	591.16	43.00	0.64	3.50	3.82	2.55	3.19	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	453.32	48.65	0.00	1.77	6.63	1.11	0.66	0.88	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	98.97	4.93	0.00	0.00	1.14	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	470.48	32.67	1.42	1.70	3.69	0.28	0.57	1.14	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	648.43	58.99	0.00	3.93	4.18	1.72	0.74	1.72	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	57.35	3.91	0.00	0.65	1.30	1.30	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	364.89	28.23	0.29	1.76	3.23	1.47	1.47	1.47	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	542.05	42.38	0.00	1.44	3.46	1.15	0.86	1.73	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	433.99	32.56	0.41	0.41	0.82	3.30	1.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	347.81	24.12	1.49	0.89	2.08	0.89	0.30	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1163.96	60.27	0.00	22.60	0.00	30.14	15.07	22.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	859.05	80.20	0.00	7.13	1.78	7.13	3.56	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1025.80	60.13	0.00	6.90	0.33	3.94	3.94	3.29	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	864.70	49.44	0.00	15.78	1.05	10.52	11.57	3.16	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	953.05	67.81	0.59	3.95	1.58	5.34	2.37	1.78	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	620.26	47.50	0.00	4.66	3.73	7.45	4.66	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	843.81	67.97	0.00	9.39	1.13	9.01	4.13	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	732.44	53.00	0.80	6.13	3.73	2.40	4.26	2.40	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1031.71	57.00	0.00	2.71	0.34	1.24	1.13	0.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	825.13	58.20	0.00	5.89	0.74	5.16	4.42	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	837.65	51.30	0.00	9.53	0.73	5.86	4.40	3.30	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	802.69	48.22	0.00	24.89	0.00	10.89	15.56	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	759.97	52.37	0.00	1.07	1.07	0.00	0.53	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	683.91	61.82	0.00	7.73	0.00	19.32	15.46	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	915.01	34.34	0.00	11.11	2.02	7.07	6.06	10.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	530.42	42.59	0.00	5.06	0.42	1.69	2.53	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	582.91	34.05	0.00	0.00	1.36	0.00	1.36	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	691.11	50.23	0.00	0.64	1.27	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	841.42	55.88	0.00	0.00	0.00	0.00	0.81	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	353.44	27.19	0.00	1.51	0.00	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	216.99	17.13	0.00	0.00	5.71	5.71	0.00	0.00	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	460.01	13.05	0.00	3.26	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	627.33	57.03	0.00	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	0.00	0.00	0.00	12.55	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	504.98	37.92	0.43	1.51	0.65	1.51	0.43	0.65	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	298.41	30.31	1.57	1.05	0.52	3.14	1.57	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	222.27	22.03	0.67	2.67	0.67	1.33	3.34	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	127.72	10.85	0.42	0.83	0.83	2.92	2.09	2.09	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	465.66	50.58	0.19	4.37	1.52	4.18	6.65	3.23	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	145.22	12.77	0.00	1.60	0.00	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	112.19	6.80	0.00	1.36	0.68	4.08	2.72	3.40	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	531.08	53.29	0.00	3.68	0.00	1.84	3.68	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	168.67	21.76	0.42	2.51	0.00	4.60	3.77	2.93	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	288.92	25.80	0.23	3.95	0.93	4.18	3.49	3.72	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	159.16	14.59	0.00	2.70	0.54	2.97	3.24	1.89	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	202.25	18.50	0.00	0.42	0.84	0.84	1.89	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	857.37	33.40	0.00	11.13	0.00	0.00	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	259.10	21.84	0.00	1.99	0.50	1.99	3.47	4.96	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	338.34	33.29	0.00	4.06	0.54	1.08	6.77	4.60	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	193.81	16.77	0.00	2.95	0.45	4.08	3.85	3.40	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	160.69	10.12	0.00	2.29	0.33	1.47	1.63	2.61	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	301.27	22.24	0.00	1.46	0.91	1.46	3.46	1.82	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	216.95	21.22	0.00	2.12	2.12	5.30	4.24	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	169.89	16.21	0.00	2.40	0.00	4.20	1.80	1.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	728.22	47.26	0.33	8.53	0.66	3.61	12.14	10.50	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	156.61	13.34	0.16	0.81	0.33	1.46	3.09	2.44	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	240.94	16.05	0.00	0.88	0.71	1.23	1.94	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	184.25	14.06	0.00	4.92	0.70	4.22	2.11	3.52	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	228.94	22.07	0.00	2.30	1.38	1.84	5.52	2.76	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	225.91	20.57	0.00	3.21	2.25	3.53	6.43	2.89	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	751.51	61.39	0.00	11.04	1.03	7.24	21.04	10.35	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	728.19	80.91	0.00	0.00	0.00	10.11	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	169.32	11.36	0.00	1.11	0.45	0.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	189.68	15.24	0.00	1.69	0.42	4.23	4.23	4.66	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	303.34	23.26	0.00	5.70	0.95	3.56	3.56	2.37	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	206.90	17.17	0.00	6.01	1.29	3.00	6.87	3.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1209.72	108.33	0.00	27.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	152.62	12.33	0.33	4.00	0.00	3.67	2.33	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	105.05	10.82	0.00	1.35	0.45	2.25	2.25	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	200.78	17.06	0.79	5.95	1.19	3.97	7.14	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	216.37	14.86	0.00	6.50	1.86	6.50	6.50	8.36	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	308.00	25.35	0.00	2.65	0.76	4.16	7.57	3.78	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	178.91	11.08	0.00	4.24	0.00	4.56	5.54	2.28	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	108.95	6.54	0.44	2.18	0.44	1.74	0.87	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	171.42	13.57	0.45	1.36	0.45	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	171.09	22.05	0.88	1.76	0.88	6.17	6.17	4.41	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	199.45	13.30	0.00	7.31	0.66	3.32	2.66	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	206.35	20.34	0.50	3.47	0.99	1.49	4.96	3.97	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	122.89	10.34	0.38	3.83	1.53	2.68	1.91	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	541.08	41.13	0.30	6.35	1.51	3.02	4.84	5.75	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	243.13	16.13	1.11	2.43	0.88	1.77	1.11	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	177.55	9.49	0.68	6.78	1.36	3.39	2.71	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	791.98	61.31	5.11	5.11	0.00	0.00	5.11	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	196.93	14.63	0.00	2.44	0.00	2.44	0.61	3.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	129.04	11.65	0.63	2.20	1.26	2.20	2.20	1.89	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	146.18	10.90	0.00	2.12	1.82	4.84	2.72	1.82	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	188.29	10.28	0.00	6.33	0.00	3.16	7.12	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	634.84	66.88	0.00	13.60	1.13	7.94	17.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	763.74	55.64	0.00	25.29	0.00	5.06	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	425.61	34.16	0.50	2.36	0.75	1.49	1.61	1.49	1.12
Myoblast, donor2	11322-117D8	361.71	30.49	0.19	4.41	0.38	2.30	2.88	2.11	0.96
Myoblast, donor3	11398-118D3	429.32	40.53	0.17	0.67	1.01	1.68	0.67	1.68	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	487.71	32.69	79.83	1.90	4.96	3.50	1.17	1.90	2.63
Natural Killer Cells, donor1	11230-116C6	502.48	44.90	0.31	0.62	3.69	1.23	0.92	0.92	1.54
Natural Killer Cells, donor2	11311-117C6	298.84	29.85	0.00	2.11	2.71	1.51	3.02	2.71	1.21
Natural Killer Cells, donor3	11387-118C1	319.52	30.74	0.18	2.02	2.94	0.74	0.92	0.37	1.66
Neural stem cells, donor1	11275-116H6	904.08	67.14	0.36	3.99	7.26	4.36	0.73	4.72	1.81
Neural stem cells, donor2	11352-117H2	673.98	53.92	0.00	1.93	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	614.47	33.00	0.00	5.69	3.41	1.14	4.55	2.28	1.14
Neurons, donor2	11574-120E8	637.15	46.89	0.00	2.42	1.54	1.76	1.32	1.32	1.10
Neurons, donor3	11655-122E8	427.53	38.64	0.00	4.11	4.11	3.29	3.29	3.29	0.82
Neutrophils, donor1	11233-116C9	1231.46	76.10	0.00	12.99	0.93	4.64	4.64	5.57	0.00
Neutrophils, donor2	11314-117C9	918.94	46.38	0.00	34.79	0.00	11.60	11.60	11.60	0.00
Neutrophils, donor3	11390-118C4	1519.78	98.96	0.00	3.67	0.00	8.55	1.83	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	492.99	34.43	0.00	1.78	1.66	0.71	0.36	0.95	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	251.37	24.42	0.00	4.88	0.98	0.33	2.93	1.95	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	278.57	23.67	2.61	0.80	0.60	1.00	1.80	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	224.37	16.66	0.00	1.65	0.55	1.51	1.38	1.24	0.69
Olfactory epithelial cells, donor2	11934-125I8	305.56	20.99	1.01	6.08	0.58	3.47	5.36	3.76	1.16
Olfactory epithelial cells, donor3	11935-125I9	293.52	23.72	0.91	2.50	0.79	2.27	1.02	1.48	0.23
Olfactory epithelial cells, donor4	11936-126A1	220.70	13.64	0.39	1.17	0.78	1.17	0.97	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	832.32	54.77	3.01	2.41	0.00	0.60	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	409.86	32.33	0.43	0.64	1.06	1.70	1.70	2.77	0.00
Osteoblast - differentiated, donor2	11353-117H3	260.63	17.15	0.00	2.29	0.00	4.57	5.72	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	210.42	13.03	0.62	1.86	0.62	3.10	1.24	0.62	0.62
Osteoblast, donor1	11277-116H8	364.69	29.71	2.74	1.56	2.54	0.78	0.98	0.59	0.78
Osteoblast, donor2	11354-117H4	498.65	54.78	2.11	0.00	2.11	0.00	0.00	0.00	2.81
Osteoblast, donor3	11426-118G4	278.50	23.64	1.07	0.71	1.60	0.71	1.07	0.53	1.07
Pancreatic stromal cells, donor1	11249-116E7	540.71	39.76	0.25	2.19	0.51	2.19	1.43	1.85	0.84
Pericytes, donor1	11491-119E6	314.44	26.82	0.33	0.56	1.67	1.11	0.33	0.33	0.22
Pericytes, donor2	11571-120E5	250.81	21.73	0.00	1.81	0.91	1.36	0.45	1.36	0.23
Pericytes, donor3	11652-122E5	375.57	36.21	3.26	1.63	1.63	1.22	0.61	1.02	1.02
Perineurial Cells, donor1	11499-119F5	475.71	33.68	1.02	0.45	1.13	0.57	0.57	0.11	0.57
Perineurial Cells, donor2	11579-120F4	449.93	41.77	0.09	1.01	1.29	0.46	0.92	0.83	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	633.34	46.54	0.00	1.27	0.96	1.27	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	322.97	16.90	0.00	2.20	1.22	0.98	3.18	1.96	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	327.16	26.79	0.26	1.42	0.78	1.16	0.65	0.78	0.26
Placental Epithelial Cells, donor1	11278-116H9	384.10	15.31	0.24	1.20	0.00	2.39	0.72	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	482.37	31.05	0.00	1.11	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	294.49	20.03	0.20	0.98	0.59	1.57	0.79	0.98	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	434.17	38.92	9.18	11.71	0.63	2.85	7.59	5.70	0.63
Preadipocyte - breast, donor1	11467-119B9	512.68	29.08	14.63	3.38	1.88	1.31	1.50	1.69	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	379.83	35.90	12.01	1.04	1.83	0.39	0.13	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	388.83	42.55	8.78	5.18	2.03	0.68	1.35	2.25	1.35
Preadipocyte - omental, donor1	11468-119C1	672.60	42.20	21.52	2.02	1.28	2.98	1.28	3.94	1.49
Preadipocyte - omental, donor2	11329-117E6	511.11	41.03	9.60	3.06	0.44	4.36	0.87	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	461.55	41.40	8.45	5.44	1.43	1.86	1.15	3.15	1.43
Preadipocyte - perirenal, donor1	11469-119C2	363.19	32.48	1.97	6.89	2.95	0.00	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	343.97	36.55	1.23	0.92	1.54	0.61	0.61	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	501.13	56.84	0.00	4.25	2.12	1.24	0.89	2.66	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	414.47	47.17	3.24	2.55	1.70	1.70	2.21	1.19	1.02
Preadipocyte - visceral, donor1	11280-116I2	563.82	53.19	2.33	1.21	1.68	0.93	0.37	1.68	1.77
Preadipocyte - visceral, donor2	11357-117H7	450.06	40.50	0.46	3.22	0.92	1.38	0.92	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	326.53	34.06	0.42	1.57	1.57	0.84	1.46	1.46	1.88
Prostate Epithelial Cells (polarized), donor1	11253-116F2	993.21	34.39	6.64	5.58	4.37	5.43	5.73	7.09	0.60
Prostate Epithelial Cells, donor2	11331-117E8	367.92	27.08	0.00	2.84	0.27	3.93	1.35	3.66	0.14
Prostate Epithelial Cells, donor3	11404-118D9	520.09	27.31	84.45	2.82	0.24	2.51	1.65	2.94	0.37
Prostate Stromal Cells, donor1	11254-116F3	648.44	45.45	11.96	1.59	1.25	0.80	1.94	3.42	2.51
Prostate Stromal Cells, donor2	11332-117E9	521.58	36.04	4.84	2.69	0.72	1.08	2.51	1.79	1.08
Prostate Stromal Cells, donor3	11405-118E1	328.26	23.77	2.50	1.98	1.15	0.94	1.98	3.13	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	595.29	51.10	2.92	0.36	0.00	1.09	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	692.15	41.66	0.76	1.52	0.49	1.18	0.83	1.25	0.14
Renal Epithelial Cells, donor1	11517-119H5	250.57	22.83	0.00	0.00	1.01	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	342.86	32.72	0.71	0.00	0.00	0.00	0.00	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	715.86	44.15	0.11	1.27	0.53	0.74	0.95	1.59	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	221.96	29.96	0.00	1.36	2.04	0.00	0.68	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	298.10	29.24	0.00	1.75	1.75	0.40	1.35	1.08	2.56
Renal Glomerular Endothelial Cells, donor3	11675-122H1	289.50	27.75	0.00	2.22	1.11	1.78	0.89	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	114.46	9.32	0.00	0.67	1.33	0.00	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	459.98	43.36	0.44	1.10	2.64	1.32	0.44	0.66	0.22
Renal Mesangial Cells, donor2	11598-120H5	397.51	43.89	0.00	0.00	0.63	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	203.07	19.70	0.00	0.55	0.83	0.00	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	908.07	76.50	3.76	0.54	1.07	1.07	0.81	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	512.78	46.81	6.75	2.53	0.42	1.69	1.69	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	323.21	26.42	0.00	0.77	1.35	1.54	1.54	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	646.91	48.23	0.00	0.78	1.30	0.26	1.81	1.81	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	507.66	42.35	0.00	2.27	1.71	1.14	1.14	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	291.24	44.25	0.00	1.03	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	603.43	22.83	10.04	1.51	1.00	0.25	1.51	0.75	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1551.91	45.97	0.27	4.54	0.40	6.95	0.80	2.81	2.54
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	445.81	25.02	8.04	2.68	2.68	3.57	1.79	0.89	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1320.34	55.04	30.82	2.75	7.15	2.75	4.40	5.50	17.61
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	482.61	24.36	4.06	0.58	2.90	1.16	0.58	2.32	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	402.82	30.95	4.29	0.91	3.51	0.78	0.65	0.78	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	322.64	23.34	3.08	1.39	3.67	1.39	0.89	0.79	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	623.50	36.03	5.13	1.00	4.24	0.78	2.12	0.45	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	556.46	38.45	4.47	0.74	3.97	0.99	1.24	0.87	4.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	390.31	29.37	2.80	2.10	3.15	1.28	2.21	1.17	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	541.77	31.43	2.77	0.92	3.24	1.85	5.08	1.16	5.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	313.25	22.59	3.56	1.10	3.15	1.10	0.82	0.55	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	366.69	21.63	2.12	1.66	3.33	1.82	0.91	0.61	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	513.74	30.82	3.40	0.36	5.91	1.08	0.36	0.36	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	387.19	29.55	2.58	0.86	3.44	0.86	0.57	0.29	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	357.79	24.47	2.04	0.97	1.61	0.75	2.04	0.75	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	412.45	31.86	3.54	1.11	5.09	0.66	2.21	0.89	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	297.66	25.24	2.68	0.57	3.06	0.76	0.38	0.57	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	288.99	19.28	2.14	0.47	3.07	0.28	0.09	0.47	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	591.34	31.57	7.70	1.69	4.70	0.94	0.94	0.38	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	230.91	18.84	2.92	0.40	2.92	0.40	0.27	0.27	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	302.24	22.39	2.82	0.88	2.92	0.29	1.17	0.88	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	432.52	29.98	2.86	0.57	3.25	0.38	2.10	0.38	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	292.40	23.17	2.35	0.64	3.10	1.07	1.17	0.64	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	364.40	21.02	2.24	3.08	2.24	1.68	1.96	0.56	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	395.46	23.93	3.25	1.03	4.27	0.85	1.54	0.51	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	249.61	16.41	2.37	0.73	2.19	0.55	0.18	0.36	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	328.78	24.16	1.59	0.74	3.43	1.47	0.98	0.49	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	419.75	27.80	3.90	1.34	4.30	0.13	2.42	0.81	5.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	512.08	38.92	4.95	0.47	4.48	0.94	1.65	0.47	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	367.86	29.17	2.38	1.98	4.17	0.79	1.79	0.40	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	446.65	30.63	3.74	0.70	3.98	0.94	2.10	0.70	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	398.54	30.27	2.28	2.28	1.87	0.62	1.45	1.04	5.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	410.12	21.68	2.65	1.99	1.99	0.88	3.98	1.33	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	324.19	21.93	1.46	0.84	3.55	0.42	1.46	0.63	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	369.84	31.49	3.36	1.62	3.50	0.54	0.94	0.67	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	194.48	17.20	1.87	0.34	2.55	0.17	0.17	0.00	3.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	343.37	25.45	2.31	1.93	3.08	1.16	0.96	0.19	4.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	440.68	35.25	2.58	2.58	3.61	0.34	0.86	0.34	4.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	220.43	17.28	0.96	0.82	1.65	0.41	0.69	0.14	3.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	383.99	26.76	2.63	1.15	3.12	1.31	3.94	2.79	4.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	329.10	26.42	0.85	1.36	3.58	1.02	0.68	0.51	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	382.47	29.74	1.33	0.74	2.96	0.89	0.59	0.89	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	268.15	17.86	1.33	0.27	2.40	0.53	1.60	0.27	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	336.82	24.20	5.95	1.38	4.42	1.24	0.55	0.97	4.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	382.39	25.72	0.24	1.19	1.43	0.71	1.43	0.71	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	340.81	15.92	0.60	0.40	2.22	1.21	0.81	0.81	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	430.28	24.96	3.86	1.32	2.45	1.32	0.75	1.13	3.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	552.34	27.95	28.30	2.79	4.19	3.84	3.84	3.14	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	396.81	17.53	17.23	1.51	5.74	1.81	0.91	0.91	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	579.26	23.87	24.11	2.81	3.18	2.94	1.84	2.81	7.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	647.42	27.36	77.14	1.02	4.66	1.75	0.87	1.02	7.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	773.31	38.33	36.51	2.43	3.65	7.30	4.26	4.87	11.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	574.16	25.02	22.30	1.81	4.82	1.51	2.41	3.01	11.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1022.82	37.32	142.27	7.24	7.92	11.54	7.46	10.40	19.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	722.19	31.45	69.49	1.80	6.59	4.19	4.79	0.90	15.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1327.39	50.89	164.01	6.38	9.56	18.54	7.56	13.34	22.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	912.90	38.85	139.38	2.35	8.11	25.61	8.11	12.59	22.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	450.73	26.44	42.67	4.21	4.21	4.21	1.20	3.61	14.42
Schwann Cells, donor1	11498-119F4	204.81	24.45	0.38	1.13	1.13	0.38	1.32	0.19	0.75
Schwann Cells, donor2	11578-120F3	350.45	23.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	284.59	31.11	0.44	1.53	1.75	0.88	1.53	0.88	0.88
Sebocyte, donor1	11220-116B5	549.41	25.75	1.64	0.55	1.10	0.00	0.55	1.64	0.55
Sebocyte, donor2	11301-117B5	252.30	18.38	1.38	1.38	0.46	0.46	1.84	1.38	0.00
Sebocyte, donor3	11378-118B1	322.57	22.67	1.03	1.24	0.41	2.47	0.41	1.03	0.21
Sertoli Cells, donor1	11255-116F4	664.30	43.07	18.22	4.97	1.66	1.66	1.66	1.66	6.63
Sertoli Cells, donor2	11333-117F1	432.13	36.72	5.65	2.82	0.00	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	490.65	27.27	35.72	0.88	1.94	2.29	0.88	2.02	0.88
Skeletal Muscle Cells, donor2	11358-117H8	172.76	10.84	12.29	0.00	1.45	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	217.37	11.70	0.00	0.84	0.84	0.00	0.84	3.34	1.67
Skeletal Muscle Cells, donor4	11451-119A2	351.73	38.80	0.00	2.67	1.10	0.16	2.04	1.41	0.31
Skeletal Muscle Cells, donor5	11455-119A6	318.40	31.81	1.04	2.68	1.34	0.74	1.34	1.34	0.59
Skeletal Muscle Cells, donor6	11459-119B1	343.05	39.86	0.00	1.23	1.08	1.39	1.69	1.08	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	597.14	45.99	4.54	1.01	2.52	2.02	1.76	1.76	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	334.60	34.82	0.00	3.00	1.43	0.29	1.00	1.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	388.80	37.90	0.10	2.48	1.09	2.28	1.49	0.99	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	386.80	28.39	10.19	0.59	1.69	0.42	0.59	1.10	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	218.58	26.06	7.24	0.72	0.72	0.72	0.72	0.72	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	224.84	19.40	0.14	2.61	1.65	1.24	1.10	0.69	0.69
Skin - palm, donor1	10286-104F7	83.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	227.91	15.86	0.14	3.75	0.14	5.05	3.75	1.87	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	384.41	26.99	0.82	4.91	2.45	1.64	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	207.33	19.08	0.26	4.41	0.78	4.93	2.21	1.95	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	734.38	36.42	16.82	3.75	0.56	2.78	2.09	4.59	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	321.82	19.41	5.77	1.69	0.42	1.41	1.83	1.69	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	486.33	27.91	0.00	2.33	1.90	2.54	0.00	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	335.63	17.84	13.19	1.65	0.30	2.17	1.27	1.50	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	77.76	7.71	1.85	0.93	0.31	0.62	1.23	0.31	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1108.10	101.16	36.46	6.89	3.33	4.45	4.22	7.11	5.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	295.68	23.51	0.59	1.18	0.59	0.00	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	383.20	37.79	1.10	0.66	1.10	0.22	0.22	0.88	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	410.71	30.32	1.58	0.39	0.39	1.58	0.79	0.00	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	382.42	27.04	0.00	0.77	0.77	0.77	0.77	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	434.33	16.01	0.00	3.00	1.00	1.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	372.22	32.20	0.00	1.33	0.67	1.20	0.40	1.60	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	391.88	35.24	0.22	2.44	1.55	1.11	3.55	3.10	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	262.46	25.48	2.94	2.30	1.41	1.41	0.26	0.51	3.33
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	375.08	28.98	0.33	0.33	1.95	1.30	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	436.20	41.35	0.00	0.59	3.25	1.77	0.00	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	272.77	24.06	0.00	1.57	0.43	1.00	1.28	0.85	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	321.77	32.05	0.00	0.49	1.79	0.33	0.65	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	270.34	18.87	3.65	0.61	0.30	1.52	0.61	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	414.20	37.38	1.01	1.01	0.51	1.01	0.25	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	195.86	18.36	6.12	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	245.09	21.46	0.95	2.86	0.00	1.91	0.95	0.95	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	420.89	31.26	0.29	1.77	1.03	0.74	0.88	0.88	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	331.90	30.99	0.65	3.01	0.65	0.86	2.58	1.94	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	330.93	31.38	0.42	1.26	0.31	1.47	1.57	1.15	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	340.91	32.17	2.01	1.08	1.55	1.08	0.46	0.31	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	245.76	18.32	0.00	1.08	2.16	2.16	2.16	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	249.54	19.43	0.00	0.90	0.60	0.60	1.79	0.90	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	327.74	32.77	0.00	0.34	0.68	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	467.41	22.62	2.91	0.79	0.39	0.71	0.55	0.79	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	381.43	25.97	0.40	2.01	1.11	2.72	1.91	3.93	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	460.79	50.97	2.73	1.82	1.14	1.14	2.05	1.37	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	328.47	36.83	0.60	3.02	1.21	1.21	1.21	0.00	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	510.51	51.40	0.26	1.32	1.85	0.53	0.53	1.06	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	555.67	42.34	2.93	1.86	0.67	2.13	0.67	2.13	2.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	391.81	28.05	11.90	3.63	1.25	2.00	2.63	3.13	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	412.71	25.11	0.51	1.01	0.51	0.76	1.01	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	393.07	37.54	1.51	0.30	1.51	0.90	0.60	1.36	2.11
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	228.05	23.26	0.75	0.00	0.75	3.00	1.50	1.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	985.96	12.92	14.21	19.38	0.00	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	317.64	25.11	0.47	0.47	2.33	0.93	0.93	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	335.75	26.25	3.03	1.01	0.50	0.50	1.01	1.01	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	285.19	24.13	2.51	3.13	0.94	0.63	0.31	1.25	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	332.46	35.40	0.88	2.36	0.29	0.59	0.88	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	472.77	40.74	0.33	0.08	0.75	0.58	0.25	0.25	1.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	300.38	23.83	0.00	2.80	0.47	0.93	0.93	1.87	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	330.87	31.81	0.72	0.72	0.72	0.58	0.14	1.15	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	296.26	28.81	0.00	1.78	0.51	2.55	1.78	1.02	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	231.85	27.45	0.56	0.75	1.13	1.13	0.19	0.75	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	521.81	49.47	0.28	1.68	1.26	0.42	0.42	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	475.83	37.20	5.28	1.17	0.50	0.59	0.67	0.67	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	114.28	10.00	0.00	0.00	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	309.74	24.47	1.22	0.98	0.73	0.73	0.49	1.47	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	399.70	34.25	1.77	1.55	1.77	2.43	1.99	2.21	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	380.06	35.40	1.46	2.34	0.88	0.88	0.88	1.17	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	298.15	22.74	0.19	1.94	0.97	0.39	1.55	1.94	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	358.33	32.00	2.12	3.97	0.53	4.76	2.64	2.12	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	602.93	50.96	0.00	4.09	1.86	2.98	2.60	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	494.45	40.61	0.00	3.95	1.08	1.08	2.52	2.16	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	295.26	24.98	0.00	1.99	0.85	1.14	2.27	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	475.01	50.02	1.18	1.58	1.58	0.39	3.15	0.79	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	385.75	35.30	0.76	5.84	1.52	2.03	5.59	2.54	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	270.34	18.77	0.00	2.00	1.20	0.80	0.80	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	308.91	32.19	0.84	5.43	1.25	1.25	2.51	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	438.65	31.63	0.92	3.67	0.46	1.38	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	476.85	29.79	1.85	1.51	1.35	2.19	1.01	2.19	0.84
Synoviocyte, donor2	11368-117I9	370.11	23.13	1.17	1.51	0.50	1.84	1.84	3.02	0.84
Synoviocyte, donor3	11440-118H9	275.91	18.77	0.00	2.90	0.89	1.12	1.56	3.80	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	507.05	53.96	0.00	0.36	1.07	0.36	0.71	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	216.04	23.78	7.93	0.00	1.98	0.00	0.00	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	157.92	11.58	0.69	0.69	0.46	0.93	0.23	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	556.34	37.78	11.61	1.79	0.65	2.15	0.43	2.08	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	271.75	21.65	0.77	2.32	0.39	2.71	1.16	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	239.95	19.47	1.15	1.15	0.00	0.00	1.15	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1559.70	51.30	0.98	6.77	0.74	12.30	1.23	2.71	3.44
Urethra, donor2	10319-105A4	142.08	3.60	0.00	0.00	0.00	5.40	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	541.15	42.51	1.33	0.53	0.53	1.06	1.33	0.80	0.00
Urothelial Cells, donor2	11600-120H7	365.72	22.03	1.20	1.60	0.00	0.80	0.00	2.00	0.00
Urothelial Cells, donor3	11681-122H7	316.99	26.82	0.92	0.69	0.00	0.46	0.46	0.92	0.00
Urothelial cells, donor0	11216-116B1	690.08	44.58	0.00	1.34	0.22	1.34	1.56	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	1267.94	104.10	0.00	1.78	1.78	3.56	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1296.66	141.53	0.00	2.86	1.43	2.86	2.86	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	664.67	50.65	0.00	5.48	0.00	3.42	4.79	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	785.09	59.91	0.00	2.75	0.69	1.72	1.38	1.38	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	918.60	77.28	0.00	1.16	0.58	1.74	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1185.97	84.34	0.00	5.21	0.00	4.16	1.04	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1150.91	103.71	0.00	3.67	0.92	2.75	1.84	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	572.39	42.91	0.00	2.74	0.00	0.91	2.74	4.56	0.00
Wilms' tumor cell line:G-401	10809-111A8	256.22	27.02	0.49	2.22	2.84	1.11	0.74	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	65.12	3.52	0.88	0.00	3.52	2.64	0.00	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	307.53	18.71	0.28	1.68	0.56	2.23	0.28	0.56	0.56
achilles tendon, donor2	10292-104G4	204.59	8.27	2.07	0.00	2.07	6.20	2.07	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	209.06	22.18	0.25	1.02	0.76	0.51	0.76	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	321.33	24.61	1.63	0.23	1.39	0.70	0.70	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	684.00	32.29	41.79	1.54	13.06	1.31	0.36	1.19	1.42
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	603.00	63.40	2.18	1.63	6.53	2.18	1.36	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	292.61	35.98	0.00	1.41	4.78	1.12	0.84	0.84	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	635.29	51.18	0.42	2.11	4.65	0.85	1.06	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	469.57	29.13	97.18	4.36	4.90	1.91	0.54	0.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	404.95	57.28	0.44	1.32	8.81	1.32	0.44	1.76	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	513.72	52.68	0.00	4.49	2.86	2.45	0.00	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	249.68	27.57	0.39	1.55	1.55	1.94	1.16	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	375.54	51.70	0.74	2.21	2.94	1.29	0.74	0.92	2.39
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	241.83	39.01	0.00	3.90	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	325.80	45.78	0.00	0.93	2.56	0.23	0.70	0.93	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	578.64	63.43	0.78	1.55	0.78	2.85	2.59	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	392.78	44.71	0.00	2.63	1.17	0.88	0.58	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	262.12	28.82	1.86	0.00	1.86	0.93	0.46	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	568.76	41.54	1.23	2.06	0.82	2.47	1.23	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	63.23	4.91	0.31	1.23	0.92	3.68	0.00	0.31	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	280.77	14.51	1.71	0.85	0.43	0.85	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	303.90	23.05	1.82	0.91	0.30	0.00	0.30	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	325.43	22.14	1.93	0.24	1.20	0.48	0.48	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	543.70	69.72	3.12	3.56	2.00	1.56	1.34	1.34	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	272.17	24.35	3.34	0.67	1.33	0.33	1.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	161.66	18.58	1.86	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	379.30	50.10	0.00	1.51	1.51	0.38	1.51	0.00	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	227.23	22.68	0.00	1.31	5.67	0.87	0.87	0.87	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	103.10	11.25	0.00	0.00	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	580.04	34.85	1.18	3.30	0.24	2.83	0.94	1.41	0.71
adipose tissue, adult, pool1	10010-101C1	657.08	39.09	0.47	3.10	1.24	3.41	1.24	1.86	0.31
adipose, donor1	10184-103D4	1090.13	80.34	0.00	15.25	5.86	36.94	21.11	10.56	0.00
adipose, donor2	10185-103D5	268.05	21.90	0.00	6.08	2.84	16.63	3.24	2.84	0.00
adipose, donor3	10186-103D6	314.22	23.69	0.00	4.08	3.00	17.70	4.90	3.81	0.54
adipose, donor4	10187-103D7	379.64	25.14	0.00	6.07	2.60	5.20	2.60	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	219.69	22.73	0.16	0.95	0.79	1.74	0.32	0.63	0.16
adrenal gland, adult, pool1	10081-102A9	170.97	43.65	0.00	0.00	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	623.94	70.44	3.60	1.33	2.80	3.07	0.53	0.40	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	635.28	46.81	0.00	2.86	3.93	7.50	2.14	1.07	3.57
amniotic membrane cells, donor1	12235-129G3	402.26	23.65	0.00	3.01	0.00	1.16	0.70	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	414.51	23.67	0.00	2.37	0.34	1.01	1.35	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	385.93	28.58	0.00	2.65	0.59	0.88	1.47	1.47	0.00
amygdala - adult, donor10196	10167-103B5	369.97	59.29	0.00	4.74	4.74	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	496.17	29.40	0.20	1.62	3.65	2.84	1.22	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	204.96	22.59	0.32	1.94	11.94	2.58	0.97	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	522.18	19.99	46.22	1.15	1.02	1.15	0.64	0.89	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	428.45	41.04	0.66	1.54	4.41	3.53	1.10	0.44	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	359.09	27.73	0.33	2.00	1.67	1.67	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	285.77	17.65	0.00	1.77	0.00	2.55	1.57	1.77	0.20
appendix, adult	10189-103D9	366.38	26.39	0.39	3.10	0.78	2.33	0.78	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	664.14	31.99	0.00	1.38	1.38	1.72	0.69	1.72	1.38
artery, adult	10190-103E1	294.84	14.95	0.00	10.87	1.36	4.08	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	569.47	23.32	1.59	1.01	2.32	0.72	0.43	1.16	0.43
b cell line:RPMI1788	10427-106D4	315.69	31.67	8.03	0.59	2.08	0.45	0.15	0.59	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	447.80	25.25	1.11	1.11	0.83	2.50	1.66	1.39	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	631.71	45.75	0.50	1.19	0.69	1.39	0.50	0.99	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	980.50	25.78	125.37	2.68	1.34	3.51	1.17	2.85	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	284.65	30.20	9.51	2.80	0.00	3.36	1.12	0.56	1.68
bladder, adult, pool1	10011-101C2	447.71	21.08	0.11	2.06	0.65	2.82	0.87	1.20	0.33
blood, adult, pool1	10053-101G8	318.91	46.51	0.00	4.43	0.00	4.43	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	338.26	21.41	0.00	0.86	1.71	0.86	1.71	0.00	0.00
bone marrow, adult	10192-103E3	508.82	41.16	0.00	4.05	0.67	3.37	5.40	4.05	0.67
brain, adult, donor1	10084-102B3	287.02	33.83	0.00	1.03	8.20	4.10	3.08	5.13	1.03
brain, adult, pool1	10012-101C3	544.43	52.45	0.00	3.23	5.23	2.67	1.89	1.78	0.22
brain, fetal, pool1	10085-102B4	267.14	29.39	0.00	2.67	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	417.25	26.76	7.93	3.96	1.98	3.63	3.30	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	757.30	33.83	0.12	0.87	0.25	1.25	0.37	0.87	0.00
breast, adult, donor1	10080-102A8	254.44	12.63	0.00	2.53	0.63	6.94	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	538.26	91.59	3.18	3.30	1.65	3.05	1.14	2.03	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	405.08	21.34	0.62	1.86	0.62	3.71	0.00	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1055.79	128.92	0.23	6.45	3.91	2.30	4.60	2.99	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	333.11	30.74	1.69	1.45	1.21	2.42	0.73	0.97	0.73
carcinoid cell line:NCI-H1770	10703-109H1	203.58	4.23	7.05	1.88	0.47	3.76	0.00	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	296.86	12.91	4.70	0.55	1.09	1.09	0.66	0.33	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	366.65	21.23	1.27	3.80	4.75	3.80	1.27	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	371.85	27.42	3.99	1.86	3.99	0.27	1.86	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	440.96	64.47	0.00	1.15	9.21	3.45	2.30	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	490.77	37.15	0.00	3.51	4.52	2.18	2.34	1.51	0.00
caudate nucleus, adult, donor10258	10379-105H1	311.77	36.68	0.00	1.53	12.23	0.76	4.58	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	364.77	23.44	0.00	1.46	9.52	2.20	1.83	1.46	1.10
cerebellum - adult, donor10196	10173-103C2	372.90	55.35	0.00	14.57	2.91	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	514.35	36.72	0.43	1.92	1.92	4.70	1.92	1.71	0.21
cerebellum, adult, pool1	10083-102B2	247.33	22.42	0.00	2.76	3.45	2.41	2.76	1.72	0.34
cerebellum, newborn, donor10223	10357-105E6	405.18	33.21	0.00	2.49	3.32	4.15	1.66	1.66	0.00
cerebral meninges, adult	10188-103D8	278.11	36.81	0.00	2.52	4.29	2.02	1.01	1.01	1.26
cerebrospinal fluid, donor2	10294-104G6	122.79	8.77	0.73	0.73	0.73	4.39	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	663.56	44.72	11.36	0.58	1.44	1.44	0.43	1.01	0.29
cervical cancer cell line:ME-180	10553-107I4	981.37	33.31	26.02	1.99	2.65	1.49	0.66	1.16	0.33
cervix, adult, pool1	10013-101C4	565.69	33.39	0.00	1.57	0.73	2.20	0.94	0.84	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	560.70	19.65	1.67	3.07	1.11	1.39	0.84	1.11	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	1.31	5.23	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	886.96	51.08	8.45	2.98	0.62	4.47	3.60	2.73	0.37
choriocarcinoma cell line:SCH	10785-110H2	509.98	20.58	3.33	2.22	1.48	0.86	1.85	1.72	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	200.18	9.01	2.13	0.71	1.42	0.95	0.24	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	467.55	20.51	0.00	2.56	0.57	2.28	1.42	1.99	1.42
chorionic membrane cells, donor2	12239-129G7	548.16	30.72	0.30	2.29	0.99	2.88	1.19	1.39	0.60
chorionic membrane cells, donor3	12240-129G8	589.60	19.78	0.00	8.24	1.10	6.59	7.14	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	375.65	45.44	2.02	1.01	10.10	1.01	6.06	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	268.17	38.04	0.00	1.73	3.07	1.54	1.54	0.58	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	244.98	29.57	0.21	1.06	0.84	1.90	1.06	0.63	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	237.80	20.29	2.57	0.77	2.57	0.26	0.51	0.26	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	240.43	22.74	1.45	0.24	3.63	1.21	1.21	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	284.04	26.67	1.63	0.00	2.04	0.20	1.02	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	434.91	39.16	1.18	0.88	0.59	2.65	0.29	0.88	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	379.47	31.54	0.26	0.52	2.35	1.30	0.00	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	543.80	39.54	0.00	4.80	0.69	1.60	5.26	3.43	0.46
clear cell carcinoma cell line:TEN	10636-108I6	1257.75	78.08	0.00	6.42	2.08	2.43	2.26	2.78	1.39
colon carcinoma cell line:CACO-2	10513-107D9	1254.20	72.48	1.10	3.29	8.97	2.20	0.55	1.28	2.01
colon carcinoma cell line:COLO-320	10420-106C6	457.62	27.37	2.66	0.38	3.42	0.00	0.38	0.38	0.38
colon, adult, donor1	10082-102B1	341.54	19.04	0.00	3.57	0.00	2.38	2.38	4.76	0.00
colon, adult, pool1	10014-101C5	768.12	35.60	0.12	1.53	0.47	5.41	1.88	1.88	2.23
colon, fetal, donor1	10070-101I7	283.04	14.21	0.00	2.47	0.62	8.65	0.62	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	64.17	4.58	0.00	0.00	4.58	0.00	0.00	0.00	13.75
common myeloid progenitor CMP, donor2	12134-128E1	350.51	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	531.59	50.99	55.24	1.27	27.20	0.85	0.85	0.42	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	627.12	70.03	49.35	1.51	12.98	2.57	0.45	0.30	3.47
cord blood derived cell line:COBL-a untreated	10449-106F8	676.57	84.75	38.07	1.97	17.06	0.85	0.99	0.71	2.54
corpus callosum, adult, pool1	10042-101F6	1135.47	80.93	0.00	2.10	3.54	2.43	1.77	1.44	1.00
cruciate ligament, donor2	10295-104G7	211.53	11.35	0.00	0.00	0.81	3.24	0.81	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	182.18	9.63	0.00	4.01	0.80	4.01	0.00	3.21	0.00
diencephalon, adult	10193-103E4	347.50	35.76	0.00	1.44	3.36	0.96	1.92	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	356.59	27.55	0.23	3.67	2.98	1.38	2.98	1.38	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	1119.10	49.49	5.90	0.51	4.10	1.80	1.28	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	399.36	20.94	16.13	2.89	0.96	1.93	1.44	0.96	1.44
ductus deferens, adult	10196-103E7	744.52	60.80	0.00	3.99	1.99	4.98	4.49	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	421.99	21.60	0.00	4.32	0.00	4.32	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	826.87	52.23	0.00	11.03	0.74	3.68	8.83	8.09	0.74
dura mater, adult, donor1	10041-101F5	668.79	35.60	0.08	1.16	1.57	1.65	0.58	0.99	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	443.70	14.43	52.85	2.00	8.66	4.22	1.55	1.33	7.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	760.17	37.40	4.30	1.72	4.87	4.59	0.86	1.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	158.47	8.63	5.55	0.62	0.00	1.23	0.00	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	355.99	17.86	13.02	2.12	0.91	1.21	2.12	1.51	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	242.99	12.66	13.58	0.93	1.23	0.31	0.62	0.62	0.62
embryonic pancreas cell line:2C6	10603-108E9	216.72	7.88	3.94	0.00	2.63	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	809.16	44.25	8.72	1.01	0.67	3.35	4.02	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	593.55	29.90	45.85	2.90	1.99	2.90	0.72	1.45	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	626.21	31.68	0.00	5.47	0.32	1.93	3.22	3.38	0.16
epidermoid carcinoma cell line:A431	10426-106D3	711.30	28.35	9.45	1.00	0.67	2.00	0.56	0.89	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	604.70	38.49	1.10	0.66	1.32	0.66	0.66	0.88	0.44
epididymis, adult	10197-103E8	523.49	43.33	0.00	8.58	2.09	4.40	2.09	2.93	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	290.24	24.13	1.42	1.06	2.66	1.95	0.35	0.89	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	208.81	10.62	4.33	0.39	1.57	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	748.43	41.67	0.13	2.62	1.44	1.70	2.88	3.93	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	657.84	35.92	3.74	2.26	1.87	1.38	2.07	1.18	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	696.94	40.78	0.34	3.58	2.02	1.23	2.69	2.46	1.12
esophagus, adult, pool1	10015-101C6	636.54	29.84	0.32	2.76	0.21	4.67	2.02	1.17	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	752.92	45.96	25.67	1.25	8.89	0.88	0.63	1.88	3.26
eye - muscle inferior rectus, donor1	10272-104E2	137.63	9.66	2.41	0.00	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	134.67	10.52	2.10	0.00	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	53.58	2.98	0.00	0.00	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	142.17	6.88	0.00	0.00	0.00	1.15	1.15	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	125.34	8.74	0.00	0.00	0.00	4.37	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	451.77	29.24	0.00	3.81	0.00	1.27	2.54	2.80	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	369.54	30.52	47.96	1.67	3.21	3.33	1.54	0.90	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	307.70	37.99	0.95	1.66	1.42	1.66	1.90	0.71	2.37
frontal lobe, adult, pool1	10040-101F4	536.86	56.86	0.00	1.13	8.82	0.56	0.75	1.22	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	761.43	37.53	1.20	4.80	1.50	6.61	3.00	2.70	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	555.20	37.85	2.56	0.37	0.37	0.91	0.64	0.37	0.82
gall bladder, adult	10198-103E9	569.54	25.59	0.00	4.35	0.48	4.35	2.66	2.66	1.21
gamma delta positive T cells, donor1	11937-126A2	668.38	115.42	0.00	1.61	3.22	0.54	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	652.12	79.93	0.00	2.99	1.12	2.61	0.75	1.87	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	496.15	29.57	2.32	5.07	0.84	1.06	3.38	1.90	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	475.22	17.41	49.32	1.35	1.74	1.16	1.35	1.35	0.77
gastric cancer cell line:AZ521	10549-107H9	424.48	41.97	1.48	0.16	2.13	1.48	0.49	0.00	0.49
gastric cancer cell line:GSS	10560-108A2	190.37	18.30	11.90	0.92	0.00	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	449.83	9.82	36.55	1.83	1.14	0.91	3.43	1.14	0.69
giant cell carcinoma cell line:LU65	10487-107B1	869.39	35.00	71.02	3.21	1.95	2.18	2.41	2.07	3.10
giant cell carcinoma cell line:Lu99B	10433-106E1	362.77	26.73	0.84	0.56	1.12	0.84	0.56	1.40	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	564.93	37.41	10.23	4.49	1.00	2.99	4.99	2.49	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	225.99	17.31	0.00	0.74	0.84	0.63	0.11	0.42	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	199.28	18.26	0.14	0.42	1.83	0.98	0.14	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	430.57	27.15	3.20	0.44	1.21	1.43	0.77	0.11	1.32
glioma cell line:GI-1	10413-106B8	543.29	31.34	24.60	0.59	1.46	1.46	0.59	3.22	2.64
globus pallidus - adult, donor10196	10175-103C4	376.85	42.28	0.00	2.92	4.37	4.37	1.46	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	656.61	45.89	0.00	2.44	1.71	2.20	1.22	1.95	0.24
globus pallidus, adult, donor10258	10367-105F7	683.23	47.92	0.00	9.58	1.37	8.22	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	354.39	20.78	0.53	1.07	2.66	5.33	1.60	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	4.89	0.00	0.00	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	338.78	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	506.98	36.59	0.00	0.00	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	238.72	13.76	0.32	1.28	0.64	0.64	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	466.00	44.53	0.00	0.92	3.21	1.84	1.84	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	548.71	55.79	0.00	1.83	1.37	1.83	1.83	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	463.10	62.48	0.00	1.29	4.51	1.29	1.93	0.00	0.64
hIPS, biol_rep1	14380-156B6	425.44	76.18	0.00	1.44	5.75	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	343.62	41.15	0.00	0.69	4.12	1.37	2.74	0.00	0.00
hIPS, biol_rep3	14382-156B8	513.11	52.97	0.00	1.10	4.41	1.10	4.41	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	260.05	37.35	4.02	1.44	5.46	1.72	0.86	0.86	2.01
heart - mitral valve, adult	10205-103F7	225.72	10.76	0.00	1.79	0.30	1.79	0.90	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	207.35	15.17	0.00	0.00	0.52	1.83	1.31	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	189.84	5.00	0.00	0.83	1.67	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	405.46	26.12	0.20	4.49	2.24	3.67	2.24	2.65	0.20
heart, adult, diseased, donor1	10051-101G6	339.39	13.63	0.85	1.70	0.43	2.13	0.00	2.13	0.85
heart, adult, pool1	10016-101C7	211.12	11.04	0.00	1.15	0.23	1.61	0.00	0.92	0.00
heart, fetal, pool1	10046-101G1	510.42	21.25	1.03	1.23	1.03	0.92	0.62	0.31	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	285.38	24.06	3.09	0.62	0.93	1.23	1.85	0.31	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	145.08	3.57	0.00	0.00	2.38	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	454.25	24.64	0.33	0.99	2.87	1.22	1.10	1.55	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	471.90	27.55	0.61	2.06	1.82	0.36	1.94	2.18	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	517.59	25.47	0.51	1.01	2.12	1.82	1.41	1.21	1.01
hepatoma cell line:Li-7	10484-107A7	2000.33	58.05	480.23	7.34	6.12	5.89	3.11	3.45	9.68
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	300.70	34.37	6.03	0.60	2.71	0.70	0.60	0.60	0.00
hippocampus - adult, donor10196	10169-103B7	315.13	55.83	0.00	1.89	9.46	6.62	0.00	2.84	3.79
hippocampus, adult, donor10252	10153-102I9	593.52	38.37	0.41	3.06	2.86	0.61	2.65	1.84	0.00
hippocampus, adult, donor10258	10374-105G5	418.78	69.22	0.00	1.49	7.97	1.00	1.49	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	169.19	15.51	0.00	1.06	4.58	3.52	1.06	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	888.05	59.20	0.00	9.77	3.05	3.05	10.38	3.66	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	426.88	28.28	0.20	2.55	2.55	4.71	2.95	1.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	456.76	34.53	0.00	2.79	1.78	3.05	4.06	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	400.91	32.14	0.00	3.38	1.69	14.66	11.84	5.07	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	375.18	24.53	0.00	11.88	2.58	24.79	20.40	12.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	553.47	39.10	0.00	6.83	2.66	15.18	8.35	4.56	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	429.46	27.15	0.29	8.17	6.42	18.39	7.01	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	419.65	28.65	0.22	9.91	3.66	20.25	6.89	6.46	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	390.38	32.53	0.83	7.09	5.00	15.01	6.67	3.75	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	578.01	34.57	0.71	4.50	5.92	8.05	2.13	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	483.60	30.86	0.48	7.55	8.52	13.82	3.54	5.46	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	543.35	40.40	0.00	2.02	7.41	10.10	1.35	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	429.86	31.77	0.16	4.07	2.50	3.44	3.91	2.03	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	486.87	35.37	0.00	7.86	3.44	7.86	7.37	8.84	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	878.86	65.46	0.00	6.11	5.24	1.75	9.60	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	461.62	29.59	0.00	9.35	2.29	19.09	7.83	7.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	438.25	38.81	0.00	6.11	3.92	18.32	5.67	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	574.73	32.48	0.00	10.49	3.00	36.48	17.49	8.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	460.43	27.51	0.19	6.97	3.77	25.06	6.78	6.97	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	494.73	31.83	0.00	10.46	3.64	21.83	8.18	7.28	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	437.28	29.76	0.31	4.39	3.13	17.23	7.83	4.07	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	480.11	32.99	0.16	7.35	6.04	14.70	7.19	4.25	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	509.49	36.29	0.00	9.29	8.13	13.35	8.42	4.64	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	402.95	26.31	0.00	6.58	5.98	13.15	6.88	4.18	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	503.06	32.52	0.37	4.25	1.85	5.36	4.06	3.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	470.43	33.38	0.00	4.85	2.85	6.28	3.42	3.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	742.72	52.67	0.00	4.49	6.12	5.31	6.94	4.49	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	512.98	43.66	0.00	8.10	2.46	18.31	10.56	7.04	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	464.34	35.16	0.00	8.55	4.43	19.00	8.55	6.97	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	510.82	36.62	0.00	5.45	1.51	16.04	6.66	4.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	436.45	30.51	0.52	4.14	3.62	13.45	4.65	3.10	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	423.07	42.51	0.66	7.31	6.64	12.62	5.31	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	322.97	15.65	1.03	3.85	4.10	7.70	2.82	1.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	521.27	29.91	0.00	5.62	7.16	12.27	8.18	3.32	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	511.13	35.59	0.76	7.57	7.57	15.90	0.76	2.27	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	462.41	32.60	0.00	3.02	6.72	11.09	5.04	3.36	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	491.47	37.67	0.00	4.35	3.38	5.55	3.62	2.90	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	592.28	49.47	0.00	6.68	3.57	7.58	11.59	5.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	506.83	47.81	0.00	4.88	3.41	7.80	4.39	6.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	508.85	40.04	0.00	5.81	2.75	13.75	5.50	3.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3435.42	276.53	0.00	45.55	13.01	65.06	78.08	26.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	784.66	62.55	0.00	12.24	3.31	28.46	10.59	7.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	523.22	42.14	0.00	6.57	6.57	20.25	6.57	4.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	468.64	36.55	0.00	5.79	4.34	13.39	5.43	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	496.44	33.81	0.71	6.05	5.34	15.66	4.63	5.34	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	502.41	28.64	0.00	7.16	4.77	7.16	5.97	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	709.63	41.03	0.14	6.50	10.56	16.52	5.82	5.01	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	398.70	28.02	0.00	3.50	4.85	8.62	3.50	3.23	0.54
immature langerhans cells, donor1	11904-125F5	633.21	30.27	0.24	1.21	0.73	0.73	1.21	0.48	2.91
immature langerhans cells, donor2	11905-125F6	350.91	19.01	0.00	4.75	0.79	0.79	2.38	0.00	0.00
insula, adult, pool1	10039-101F3	558.91	56.97	0.00	0.85	10.22	0.57	0.47	0.28	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	463.99	23.09	0.00	2.28	0.65	3.90	0.98	3.58	0.33
kidney, adult, pool1	10017-101C8	1434.12	71.49	0.10	3.90	2.30	6.71	2.50	3.20	1.40
kidney, fetal, pool1	10045-101F9	1054.88	46.90	0.07	1.91	1.63	1.20	0.78	0.92	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	821.16	39.77	5.54	0.99	2.98	1.42	1.70	1.56	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	417.08	19.77	9.12	2.76	0.83	1.24	1.24	1.94	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	311.03	17.43	5.50	1.28	0.55	1.47	0.92	1.10	0.73
left atrium, adult, donor1	10079-102A7	190.70	20.70	0.00	1.63	0.54	2.18	1.09	1.09	0.00
left ventricle, adult, donor1	10078-102A6	197.21	10.11	0.51	2.02	0.51	3.03	2.02	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	99.05	8.48	0.00	0.55	0.82	0.27	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	426.43	45.98	0.00	3.95	1.08	1.44	7.54	4.31	1.80
leiomyoma cell line:15242A	10570-108B3	378.81	49.46	0.00	2.72	0.00	1.09	4.35	3.26	2.17
leiomyoma cell line:15425	10571-108B4	420.07	40.79	0.49	4.37	1.70	1.21	6.07	2.91	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	393.66	19.05	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	302.16	43.91	1.05	1.05	3.14	1.05	0.00	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	482.39	38.01	53.24	0.83	4.60	1.42	0.47	0.83	7.32
liposarcoma cell line:KMLS-1	10782-110G8	355.53	30.77	0.31	2.19	2.66	3.44	0.94	1.72	2.03
liposarcoma cell line:SW 872	10726-110A6	283.89	21.69	0.00	0.85	2.92	1.58	1.34	0.85	2.56
liver, adult, pool1	10018-101C9	1893.04	56.88	3.57	3.40	0.81	9.40	3.24	4.21	7.62
liver, fetal, pool1	10086-102B5	359.35	22.58	0.00	4.70	0.94	3.76	3.76	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	272.11	22.17	0.00	1.31	3.06	3.94	0.44	0.87	0.00
locus coeruleus, adult, donor10252	10165-103B3	529.48	38.94	1.29	2.03	2.77	2.40	1.85	1.11	0.18
locus coeruleus, adult, donor10258	10375-105G6	446.34	47.12	0.00	9.87	3.67	8.46	7.62	5.08	0.56
locus coeruleus, newborn, donor10223	10362-105F2	752.91	62.67	0.00	5.47	5.47	13.04	1.26	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	397.75	22.00	24.22	0.28	2.08	1.38	0.14	0.28	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	554.97	37.92	0.69	0.69	0.69	1.38	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	461.75	19.90	16.74	1.71	2.77	2.24	1.71	2.24	0.53
lung, adult, pool1	10019-101D1	748.10	29.06	1.89	3.19	1.30	5.32	1.42	1.54	0.71
lung, fetal, donor1	10068-101I5	1352.55	56.80	0.00	3.14	2.57	3.14	0.57	2.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	432.56	22.45	0.92	7.33	0.92	12.37	4.12	4.12	0.00
lymph node, adult, donor1	10077-102A5	265.56	27.46	0.00	3.31	0.47	2.84	4.26	1.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	416.88	41.21	1.32	1.32	2.41	1.75	0.66	0.66	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	431.05	28.83	0.30	1.81	4.08	1.66	0.75	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	799.37	33.98	56.92	0.00	1.70	2.55	3.40	0.00	0.85
mature adipocyte, donor1	12231-129F8	378.28	31.08	0.00	0.00	0.44	2.22	0.00	0.00	2.66
mature adipocyte, donor2	12232-129F9	550.16	45.24	0.00	1.66	0.21	1.87	1.25	0.21	2.91
mature adipocyte, donor3	12233-129G1	586.97	45.28	0.24	2.13	0.24	1.42	0.24	0.24	1.66
mature adipocyte, donor4	12234-129G2	715.95	54.75	0.00	1.58	0.26	0.53	1.32	0.26	2.63
maxillary sinus tumor cell line:HSQ-89	10414-106B9	512.26	27.88	19.54	0.48	1.67	1.67	0.48	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	342.92	60.91	0.00	1.13	2.26	1.13	0.00	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	389.15	26.11	0.00	0.92	2.39	1.66	0.37	0.74	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	271.31	49.88	0.00	1.59	4.45	1.91	1.27	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	472.98	61.84	0.00	5.54	10.24	3.41	4.26	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	315.73	43.37	0.00	6.24	6.58	3.54	6.92	5.06	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	443.34	30.98	0.00	1.70	1.27	2.76	1.49	1.70	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	389.10	75.12	0.00	0.00	5.78	1.93	3.85	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	732.03	157.89	0.00	14.35	0.00	14.35	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	193.82	21.18	0.00	0.72	11.49	0.72	0.36	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	567.21	46.73	0.00	1.95	6.49	6.49	2.60	1.30	3.24
medulla oblongata, adult, donor10252	10155-103A2	716.74	40.87	0.31	2.48	4.02	2.79	1.39	1.24	4.49
medulla oblongata, adult, pool1	10038-101F2	794.15	57.22	0.16	0.73	3.84	1.55	0.24	0.49	0.49
medulla oblongata, newborn, donor10223	10361-105F1	465.22	30.55	0.35	3.47	4.17	2.08	1.74	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	312.86	28.56	0.66	1.77	2.88	0.66	1.33	1.33	0.44
medulloblastoma cell line:ONS-76	10759-110E3	118.24	11.98	0.00	0.37	0.98	0.98	0.12	0.12	0.37
melanoma cell line:COLO 679	10514-107E1	413.27	34.21	8.19	0.86	6.18	1.72	1.44	1.72	5.61
melanoma cell line:G-361	10465-106H6	368.37	36.10	6.52	2.17	1.36	1.09	1.36	3.80	0.54
meningioma cell line:HKBMM	10691-109F7	306.81	16.82	5.07	2.53	0.90	0.54	2.35	2.89	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	336.60	16.74	0.88	5.29	4.41	3.52	3.52	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	221.12	18.66	0.00	0.78	1.81	0.78	1.81	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	505.57	56.00	6.14	1.84	0.92	0.77	2.30	1.38	2.30
mesenchymal precursor cell - adipose, donor2	11748-123G2	350.47	25.81	20.90	1.09	1.09	1.09	1.27	0.73	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	548.27	54.25	6.63	2.48	1.66	0.41	2.90	0.83	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	389.68	33.85	0.28	1.83	0.98	0.84	1.40	0.84	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	394.77	35.43	0.39	1.73	0.77	0.00	1.16	1.54	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	537.22	51.36	2.78	2.78	1.39	1.39	1.39	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	607.93	41.88	79.81	3.26	0.69	1.20	2.75	3.78	3.09
mesenchymal precursor cell - cardiac, donor2	11753-123G7	394.85	32.55	3.34	2.65	0.35	0.58	0.92	1.73	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	394.33	41.12	0.40	1.46	0.80	1.33	1.99	1.33	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	474.80	41.73	0.95	0.95	0.81	0.54	1.49	1.76	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	408.58	36.99	0.57	1.56	1.71	0.57	1.00	0.85	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	566.82	43.15	14.16	1.32	1.98	2.31	0.99	1.98	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	436.98	38.88	0.83	1.38	0.97	1.11	2.08	0.97	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	481.04	38.75	3.14	2.79	0.00	1.40	1.75	0.35	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	421.40	36.75	2.04	2.86	1.02	0.41	1.84	1.02	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	382.10	29.48	3.24	0.72	1.44	0.72	1.80	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	453.11	38.38	1.14	1.86	0.21	0.52	0.93	1.86	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	432.04	25.76	0.46	3.88	0.68	1.14	1.82	1.60	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	711.99	60.42	1.26	4.62	2.94	2.10	2.10	2.52	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	480.29	38.85	0.15	2.09	0.90	0.60	2.24	2.54	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	450.52	35.89	3.50	1.14	0.70	0.44	2.10	1.84	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	621.82	44.55	0.37	4.05	1.10	1.47	1.47	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	390.89	29.19	1.43	4.01	1.43	1.43	1.43	0.29	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	520.37	40.00	0.00	5.47	1.68	1.26	3.79	3.37	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	337.48	32.42	6.85	2.74	0.46	1.37	0.91	1.37	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	423.32	42.20	8.70	2.56	1.53	1.53	2.56	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	396.56	37.95	7.85	1.83	0.52	0.79	1.05	1.31	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	401.44	30.19	7.70	1.85	0.62	2.16	1.23	2.77	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	432.82	33.19	6.35	3.06	0.71	0.94	2.59	2.35	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	412.58	34.86	10.15	2.37	0.00	1.35	2.03	1.69	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	396.12	34.19	4.32	2.36	0.79	1.96	0.79	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	417.97	25.02	4.17	2.32	1.39	1.39	2.32	2.32	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	386.43	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	502.71	45.57	5.77	2.02	0.58	1.15	1.44	2.02	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	424.34	36.14	4.46	2.68	1.12	1.56	1.12	1.34	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	430.47	31.73	7.69	3.36	1.68	1.44	1.44	0.96	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	404.80	31.53	6.60	2.93	1.47	0.73	3.67	1.47	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	423.93	35.92	6.04	2.35	1.01	1.68	1.01	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	434.35	32.34	6.55	3.28	1.64	1.23	2.87	2.05	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	433.85	24.06	8.16	2.15	0.86	1.72	1.72	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	380.08	27.34	2.73	2.73	2.73	2.73	0.00	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	428.69	20.66	5.16	5.16	0.00	10.33	5.16	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	394.62	35.73	7.15	5.52	0.97	2.27	1.62	1.62	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	384.12	34.92	7.27	4.36	0.00	1.45	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	392.35	42.11	9.60	4.26	1.07	2.67	0.53	1.07	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	372.09	26.17	6.54	4.09	0.00	1.64	0.82	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	335.85	36.54	2.33	3.11	1.94	1.94	2.72	1.94	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	339.99	44.07	8.39	8.39	4.20	2.10	8.39	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	377.52	36.76	8.94	4.97	2.98	0.99	1.99	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	433.82	38.14	9.53	9.53	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	354.59	37.95	4.15	5.34	1.19	1.19	0.59	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	406.97	41.43	2.44	3.66	0.00	2.44	3.66	1.22	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	514.00	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	381.30	36.74	7.60	6.97	0.00	1.90	1.90	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	336.63	30.35	4.48	1.72	1.03	1.72	1.03	1.03	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	313.78	23.64	2.15	6.45	0.00	2.15	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	407.16	43.91	7.98	3.99	0.00	0.00	11.98	15.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	354.72	24.11	13.78	10.33	0.00	0.00	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	347.16	27.30	5.30	3.26	0.41	0.41	0.81	1.63	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	389.28	28.60	3.18	0.79	1.59	1.59	1.59	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	360.79	18.28	3.54	5.31	0.59	1.18	1.18	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	334.77	20.57	2.49	3.12	0.62	2.49	1.87	2.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	358.23	14.70	4.01	8.02	0.00	4.01	0.00	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	307.49	27.20	0.00	3.55	0.00	3.55	1.18	4.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	390.34	25.68	0.00	0.00	0.00	5.14	5.14	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	339.38	26.85	0.69	3.44	1.38	0.69	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	577.94	39.09	0.00	3.96	0.99	1.98	2.97	2.97	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	412.71	33.65	0.00	3.36	1.12	1.12	2.24	4.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	508.21	35.62	0.00	5.72	1.91	3.82	2.54	3.82	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	758.01	48.36	0.00	4.43	1.61	3.63	2.82	3.22	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	920.21	71.96	0.00	17.44	0.00	4.36	8.72	4.36	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	852.73	67.15	0.00	10.14	2.53	1.27	7.60	2.53	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	456.99	47.34	7.28	2.43	1.21	2.43	3.03	3.03	12.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	555.83	67.78	4.52	27.11	0.00	0.00	9.04	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	546.10	49.42	15.65	4.12	0.82	1.65	5.77	3.29	12.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	472.06	42.26	0.20	2.58	0.60	3.37	0.79	1.19	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	369.60	28.23	0.00	2.92	0.00	1.95	1.62	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	424.77	37.69	0.00	6.11	1.02	1.02	5.09	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	164.80	14.70	0.77	0.00	3.87	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	307.11	17.25	2.36	0.47	0.47	1.65	0.47	0.94	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	324.81	24.09	2.32	0.93	1.85	2.32	0.70	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	371.80	34.19	4.27	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	889.51	45.93	1.03	2.88	1.13	2.26	4.11	2.88	1.23
mesothelioma cell line:Mero-25	10850-111F4	586.90	56.06	15.66	4.09	9.31	3.18	0.68	1.82	3.63
mesothelioma cell line:Mero-41	10851-111F5	487.73	48.41	0.49	2.20	0.49	1.47	0.49	0.73	1.22
mesothelioma cell line:Mero-48a	10852-111F6	418.50	39.86	0.00	2.88	1.55	1.33	0.89	1.11	1.77
mesothelioma cell line:Mero-82	10853-111F7	510.63	34.69	12.09	2.63	2.89	1.58	4.73	1.84	2.63
mesothelioma cell line:Mero-83	10854-111F8	339.59	25.53	0.17	2.38	1.02	1.02	1.19	0.00	1.36
mesothelioma cell line:Mero-84	10855-111F9	537.14	32.10	0.00	2.27	2.02	2.02	0.76	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	522.99	49.48	0.21	2.90	0.83	1.04	0.62	2.07	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	469.11	42.24	0.17	3.31	2.82	1.66	1.66	1.66	2.32
mesothelioma cell line:NCI-H226	10846-111E9	652.29	55.38	0.18	1.63	0.90	1.45	3.80	0.90	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	459.34	46.46	0.17	2.73	1.20	2.05	0.85	0.51	1.20
mesothelioma cell line:NCI-H28	10845-111E8	436.92	46.06	0.76	4.83	3.56	1.78	2.54	2.04	1.78
mesothelioma cell line:No36	10857-111G2	289.67	24.79	2.28	1.96	0.33	1.96	1.96	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	573.06	43.35	0.00	2.71	2.98	2.98	2.44	1.63	2.17
migratory langerhans cells, donor1	11901-125F2	884.76	78.11	0.77	3.65	1.73	2.11	2.11	2.30	0.58
migratory langerhans cells, donor2	11902-125F3	543.05	38.34	1.10	0.85	0.49	1.95	0.85	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	604.85	50.25	0.18	1.62	1.62	0.36	0.36	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	721.52	25.47	68.89	13.39	2.29	6.86	6.53	5.88	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	370.46	24.16	0.64	3.18	2.54	2.54	3.39	2.54	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	228.28	16.36	11.29	0.46	1.84	2.30	0.69	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	317.22	40.15	0.95	2.09	3.04	1.14	0.38	0.76	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	353.32	26.06	24.76	0.74	1.11	0.92	0.18	1.29	0.18
myeloma cell line:PCM6	10474-106I6	1167.42	67.21	468.27	3.95	1.19	8.50	1.78	3.16	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	158.27	9.13	0.00	0.00	0.00	1.01	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	496.63	37.07	0.20	1.77	0.78	0.98	0.20	2.16	2.35
nasal epithelial cells, donor1, tech_rep1	12226-129F3	679.13	38.22	41.67	1.00	0.45	0.67	0.56	0.33	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	837.77	43.39	50.23	1.25	0.22	1.03	1.62	0.59	0.37
nasal epithelial cells, donor2	12227-129F4	527.15	40.85	11.04	0.55	1.10	1.66	1.66	2.76	0.55
neuroblastoma cell line:CHP-134	10508-107D4	231.90	16.79	16.79	0.46	3.45	0.23	0.00	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	264.73	38.91	0.00	0.00	4.30	0.56	0.00	0.00	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	624.65	24.25	11.81	2.32	3.59	2.53	1.27	1.90	0.00
neuroblastoma cell line:NH-12	10555-107I6	248.96	18.08	0.19	0.37	2.42	0.93	0.37	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	252.88	11.86	0.24	2.14	3.08	1.42	0.95	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	540.87	29.93	2.53	4.59	2.22	5.23	2.38	3.01	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	209.91	12.08	0.40	0.81	0.20	1.41	0.20	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	132.88	10.81	0.64	0.64	4.45	0.64	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	205.48	21.03	1.33	1.33	0.53	1.06	0.80	1.06	1.60
neutrophil PMN, donor1	12133-128D9	133.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	504.67	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	378.83	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	884.84	79.66	3.72	2.03	12.35	1.52	1.52	0.17	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	846.14	63.24	0.80	2.40	4.00	0.80	1.60	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	415.51	28.53	0.32	5.13	2.24	2.89	1.60	2.56	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	525.79	32.58	0.00	3.68	0.26	2.10	3.15	2.89	2.10
nucleus accumbens, adult, pool1	10037-101F1	555.59	58.31	0.19	0.75	9.19	1.12	1.03	0.75	0.47
occipital cortex - adult, donor10196	10172-103C1	370.87	57.69	0.00	0.00	10.30	4.12	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	468.56	28.98	0.00	1.88	2.68	0.54	1.61	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	197.62	19.65	0.00	0.36	6.55	1.09	0.73	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	294.41	32.01	0.00	3.94	3.94	4.99	1.57	1.05	0.52
occipital lobe, fetal, donor1	10073-102A1	191.38	21.46	0.00	5.15	3.43	2.57	0.86	0.43	0.43
occipital pole, adult, pool1	10036-101E9	478.65	53.22	0.00	0.95	4.73	0.39	0.95	0.24	0.16
olfactory region, adult	10195-103E6	359.75	37.64	0.00	3.44	4.39	2.10	1.91	1.34	0.38
optic nerve, donor1	10277-104E7	304.16	16.01	0.00	2.00	2.00	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	755.21	31.55	87.14	2.28	1.82	1.48	1.48	2.62	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	653.82	28.58	9.75	1.10	1.24	1.24	0.69	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	548.27	25.57	3.22	6.10	1.02	1.52	3.89	2.03	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	563.68	42.16	2.89	2.54	3.00	1.16	1.39	1.39	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	335.12	26.75	4.41	1.18	0.29	2.06	0.59	1.76	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	241.99	8.41	0.00	0.00	0.93	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	382.34	17.18	6.57	0.85	2.54	1.27	0.21	1.27	1.27
ovary, adult, pool1	10020-101D2	505.42	24.02	0.09	1.05	0.79	3.32	0.79	0.61	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	242.35	24.20	5.50	1.10	1.65	2.20	1.28	2.20	0.37
pancreas, adult, donor1	10049-101G4	785.43	46.09	3.76	4.70	0.00	2.82	3.76	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	530.56	17.33	1.12	3.07	1.12	4.75	2.80	3.35	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	522.98	26.23	1.53	4.26	2.04	1.70	2.73	1.70	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1020.65	43.88	0.33	1.49	2.32	1.99	1.99	2.32	0.66
paracentral gyrus, adult, pool1	10035-101E8	481.68	55.74	0.00	1.46	5.40	1.01	0.55	0.55	0.46
parietal cortex, adult, donor10258	10373-105G4	429.39	52.85	0.00	2.20	4.40	0.73	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	304.72	47.02	0.00	2.82	9.40	1.88	4.70	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	425.27	28.50	0.00	2.28	1.43	1.14	1.14	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	521.58	56.75	0.00	1.06	6.08	0.44	0.35	0.70	0.53
parietal lobe, fetal, donor1	10072-101I9	289.01	16.49	0.00	2.91	6.79	0.97	3.88	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	243.01	27.29	0.00	1.12	9.72	0.37	0.75	0.37	0.75
parotid gland, adult	10199-103F1	949.05	46.87	0.00	7.40	1.23	2.47	5.55	5.55	0.00
penis, adult	10200-103F2	308.30	22.02	0.00	6.98	0.54	2.69	4.83	4.30	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	275.93	10.04	0.19	0.93	0.37	1.12	0.74	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	490.12	30.16	3.35	1.46	0.58	3.50	2.48	1.75	0.15
pineal gland - adult, donor10196	10179-103C8	217.37	38.06	0.00	1.94	1.94	3.87	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	506.34	58.04	0.00	1.18	1.18	2.96	1.18	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	263.37	29.47	0.00	3.76	1.88	3.14	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	425.97	48.57	0.00	4.05	3.04	3.04	0.00	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	569.13	45.34	1.56	0.52	0.52	4.17	0.52	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	325.17	27.24	1.70	0.85	1.70	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	633.73	32.14	0.00	1.40	0.65	1.29	0.86	0.75	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	416.35	31.65	32.97	2.52	5.69	0.93	1.06	1.32	1.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	446.53	21.63	0.00	1.87	1.09	2.65	1.09	0.78	1.56
pons, adult, pool1	10033-101E6	509.78	48.03	0.09	0.86	4.22	1.12	0.43	0.09	0.77
postcentral gyrus, adult, pool1	10032-101E5	490.45	56.32	0.00	1.13	6.45	0.70	1.05	1.05	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	10.46	0.00	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	782.14	49.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	950.60	70.41	0.00	11.74	0.00	11.74	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	645.14	30.88	9.76	2.18	1.02	3.35	1.02	1.31	1.02
prostate cancer cell line:PC-3	10439-106E7	519.28	28.13	0.36	0.73	1.63	3.63	1.63	1.63	0.18
prostate, adult, pool1	10022-101D4	488.19	28.21	0.00	0.73	0.54	2.63	0.73	1.00	0.09
putamen, adult, donor10196	10176-103C5	381.71	45.09	0.00	1.18	7.55	2.12	1.18	1.18	0.47
putamen, adult, donor10252	10152-102I8	315.68	23.53	0.00	1.96	0.00	1.96	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	433.85	89.61	2.19	2.19	3.28	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	354.20	46.39	0.72	0.24	4.35	1.69	2.17	0.24	0.24
putamen, newborn, donor10223	10365-105F5	678.44	54.73	0.00	2.25	14.99	6.75	0.75	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	295.59	6.11	13.67	0.29	1.16	0.58	0.87	1.16	0.29
rectum, fetal, donor1	10067-101I4	139.10	8.35	0.00	2.78	1.39	5.56	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	775.07	37.31	0.00	3.39	3.39	2.33	1.48	0.85	2.76
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	824.69	46.39	0.83	5.80	5.38	4.56	1.66	3.31	9.53
retina, adult, pool1	10030-101E3	680.59	47.81	0.00	1.59	2.39	1.79	1.69	0.60	0.50
retinoblastoma cell line:Y79	10475-106I7	307.09	32.48	0.26	1.04	10.65	0.26	0.00	0.52	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	257.45	20.66	0.12	1.23	1.35	2.09	0.37	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	300.88	18.28	0.00	0.56	3.09	0.28	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	129.59	10.61	0.00	0.00	0.76	0.76	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	282.28	17.48	1.46	0.32	0.97	1.13	1.29	0.97	0.97
salivary acinar cells, donor2	11772-123I8	257.34	13.63	0.28	1.51	0.28	1.38	1.38	1.24	0.14
salivary acinar cells, donor3	11773-123I9	96.00	6.62	0.66	1.32	0.00	0.66	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	1649.51	77.21	0.57	1.14	0.00	1.14	1.14	2.29	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	559.24	35.75	5.40	1.77	1.43	1.77	0.93	1.43	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	495.83	33.15	3.53	1.29	1.29	2.59	0.59	1.41	1.18
seminal vesicle, adult	10201-103F3	590.97	54.49	0.00	14.28	2.65	15.34	6.88	8.47	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	582.53	48.58	0.49	3.40	0.24	0.97	4.13	2.92	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	576.99	30.95	0.00	3.77	0.50	1.01	1.76	1.51	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	602.12	54.19	0.00	4.01	1.00	2.01	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	946.83	30.36	0.81	3.36	2.69	1.07	1.88	2.15	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	1486.60	56.26	43.33	3.09	4.09	3.32	2.10	2.32	7.63
signet ring carcinoma cell line:NUGC-4	10483-107A6	1102.78	66.84	0.26	2.58	2.58	2.06	2.19	1.42	5.55
skeletal muscle - soleus muscle, donor1	10282-104F3	109.95	4.26	0.00	2.13	0.00	2.13	0.00	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	300.92	12.47	0.00	1.32	0.48	1.68	0.96	0.72	0.48
skeletal muscle, fetal, donor1	10066-101I3	152.76	8.04	0.00	0.00	0.00	7.04	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	217.13	40.71	0.00	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	400.20	29.04	0.00	6.94	0.00	8.84	0.00	3.16	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	606.68	71.04	0.00	4.34	7.67	6.34	0.67	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	262.57	14.18	0.00	1.58	2.21	0.63	1.58	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	519.65	52.04	0.00	3.08	2.89	2.89	1.54	0.96	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	699.36	48.79	17.80	1.32	2.47	1.48	0.82	1.15	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	631.01	28.47	0.00	2.90	1.29	1.13	1.93	1.29	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	463.07	17.65	1.96	1.74	3.27	0.65	1.31	0.22	1.96
small intestine, adult, pool1	10024-101D6	1527.56	61.27	0.00	4.66	0.72	12.78	2.39	3.58	7.41
small intestine, fetal, donor1	10064-101I1	556.50	24.32	0.00	7.13	1.47	3.19	2.95	2.95	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	778.07	48.73	2.05	8.21	0.00	4.62	6.67	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	251.48	17.32	0.00	1.81	0.00	1.29	0.78	1.55	0.00
somatostatinoma cell line:QGP-1	10781-110G7	249.53	13.67	56.55	1.88	1.61	1.61	1.34	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	427.61	27.99	0.00	2.75	3.67	3.90	0.92	1.15	0.69
spinal cord, adult, donor10252	10159-103A6	760.55	52.44	0.79	1.58	1.97	4.34	0.79	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	1081.97	134.21	0.00	2.08	2.77	2.08	5.53	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	559.22	43.91	0.00	7.32	4.88	4.88	1.22	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	680.09	44.08	0.00	2.76	1.84	4.13	3.67	2.30	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	261.22	20.76	2.54	1.64	1.64	1.05	0.45	0.75	1.94
spleen, adult, pool1	10025-101D7	499.02	35.35	0.11	1.32	0.66	1.76	1.10	1.21	0.44
spleen, fetal, pool1	10044-101F8	505.02	34.48	0.16	1.11	1.19	0.72	0.24	0.40	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	503.07	64.18	4.24	1.04	3.11	0.62	0.41	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	571.34	16.14	22.41	1.71	0.38	3.04	0.76	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	744.33	44.03	0.70	4.54	1.05	2.10	3.49	4.19	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	392.89	22.28	6.65	2.74	0.78	2.74	1.95	0.00	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	868.62	55.15	0.79	2.03	1.58	1.69	0.68	0.90	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	304.15	10.59	13.56	2.12	0.85	0.00	1.69	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	302.07	17.35	0.00	1.69	0.85	0.42	0.85	0.85	0.42
stomach, fetal, donor1	10062-101H8	291.56	16.02	0.00	2.14	1.07	1.07	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	690.45	34.18	0.00	11.96	1.14	3.99	4.56	4.56	0.00
substantia nigra - adult, donor10196	10178-103C7	814.11	108.55	0.00	54.27	0.00	108.55	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	697.48	39.67	0.83	2.28	1.45	4.15	1.66	1.87	0.21
substantia nigra, adult, donor10258	10371-105G2	522.42	63.62	0.00	1.03	5.17	4.14	1.55	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	398.51	27.56	0.00	2.12	5.65	4.24	2.83	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	425.75	36.45	0.00	1.83	2.75	2.98	1.15	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	524.22	56.46	0.00	1.61	6.95	1.27	1.02	1.02	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	225.79	19.23	0.00	5.70	7.83	4.27	0.00	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	295.81	29.45	0.00	3.08	4.83	1.76	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	468.84	44.68	0.00	8.73	0.35	1.40	1.75	2.79	0.35
tenocyte, donor2	11765-123I1	482.22	38.53	0.00	2.67	0.38	1.91	3.43	2.29	0.38
tenocyte, donor3	11768-123I4	498.17	42.26	0.00	4.45	0.74	2.22	3.34	3.34	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	368.81	28.38	0.00	2.72	2.72	2.21	0.85	0.68	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	448.57	27.44	0.00	2.31	3.24	3.08	1.39	2.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	338.78	25.42	0.15	2.17	1.55	1.39	0.77	1.55	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	640.96	51.41	2.16	3.17	1.78	4.19	2.29	3.81	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	564.23	32.52	3.78	1.89	1.51	0.76	1.13	1.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	421.09	20.83	0.11	1.31	1.20	1.96	1.20	1.20	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	388.89	62.53	0.33	2.61	3.26	2.28	3.91	2.61	0.00
testis, adult, pool1	10026-101D8	541.16	54.44	0.00	3.11	2.90	5.91	1.83	1.40	27.59
testis, adult, pool2	10096-102C6	508.82	75.78	2.71	4.51	9.02	3.61	2.71	0.45	82.10
thalamus - adult, donor10196	10168-103B6	507.83	51.89	0.00	4.42	0.00	4.42	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	672.80	29.07	0.00	2.03	1.56	2.19	1.41	1.41	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	872.96	150.88	0.00	0.00	6.16	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	312.58	32.11	0.00	4.78	2.80	5.60	4.12	2.96	0.16
thalamus, newborn, donor10223	10366-105F6	266.37	24.16	0.00	1.73	18.41	4.60	1.15	0.58	1.15
throat, adult	10209-103G2	447.91	25.22	0.00	7.24	0.25	2.75	0.75	1.25	0.50
throat, fetal, donor1	10061-101H7	325.43	18.89	0.00	6.40	0.91	2.13	2.13	2.44	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	404.02	31.00	0.00	2.38	2.58	0.99	0.60	0.79	0.00
thymus, adult, pool1	10027-101D9	548.27	35.69	0.10	1.39	2.88	3.28	0.60	0.99	0.10
thymus, fetal, pool1	10043-101F7	568.25	38.24	0.10	1.25	1.77	1.35	0.62	1.14	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	579.44	51.06	17.82	2.79	1.46	0.93	3.06	2.39	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	328.41	21.37	0.98	1.40	0.98	1.54	0.56	0.42	0.70
thyroid, adult, pool1	10028-101E1	1338.48	36.67	0.65	3.08	0.56	5.51	2.15	2.80	0.28
thyroid, fetal, donor1	10060-101H6	407.89	25.05	0.00	3.43	0.79	6.06	1.58	2.37	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	9.24	0.00	0.00	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	366.31	21.40	0.23	5.81	0.23	1.86	2.56	3.26	0.23
tongue, fetal, donor1	10059-101H5	375.96	28.37	0.00	4.34	0.39	2.36	0.79	4.34	0.00
tonsil, adult, pool1	10047-101G2	662.66	43.48	0.40	1.50	1.50	1.10	0.40	0.60	0.30
trachea, adult, pool1	10029-101E2	747.88	36.40	0.33	1.88	0.57	2.29	0.82	1.47	0.41
trachea, fetal, donor1	10058-101H4	335.84	20.00	0.00	2.69	0.00	5.77	2.69	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	286.96	30.82	0.35	1.42	1.42	0.71	0.35	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	337.69	19.76	0.81	1.01	3.24	1.22	0.10	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	541.67	34.00	21.15	3.13	0.78	3.29	2.19	2.82	0.94
tridermal teratoma cell line:HGRT	10694-109G1	68.49	1.90	0.00	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	530.84	32.84	3.13	2.03	1.78	1.19	1.35	1.95	1.44
umbilical cord, fetal, donor1	10057-101H3	275.42	18.78	0.00	2.09	0.00	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	577.92	34.47	0.00	1.02	1.54	1.02	0.51	0.51	1.19
uterus, fetal, donor1	10055-101H1	269.27	23.55	0.00	3.07	1.02	3.58	2.05	1.54	0.00
vagina, adult	10204-103F6	253.96	10.34	0.00	0.00	0.00	1.29	0.00	1.29	0.00
vein, adult	10191-103E2	365.62	29.37	0.00	4.60	1.10	1.32	0.88	0.44	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	206.42	21.90	9.08	0.53	1.60	0.27	0.27	0.00	0.00